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Heat shock protein 60 (Hsp60) is a mitochondrial stress protein that is elevated in 
response to mitochondrial impairment.  It is involved in protein folding and, more 
recently, it has been identified as a signalling molecule.  It has been found 
elevated in patients suffering from diabetes, atherosclerosis and cardiomyopathy.  
In order to investigate the translocation of Hsp60 from mitochondria we employed 
RG224428, a plasmid housing genes for a human Hsp60 connected to a green 
fluorescent protein (GFP) bound at the C-terminus.  The plasmid was cloned 
inside DH5α E. coli (DH5α) and purified using an endotoxin-free plasmid 
extraction kit.  Using endotoxin-free DNA we transfected the human cervical 
cancer cell line HeLa with the Hsp60-GFP DNA.  It has been found that 
endotoxin (or otherwise known as lipopolysaccharide) can affect Hsp60 
expression in mammalian cells, so by using endotoxin-free plasmid DNA we 
could induce controlled stress treatments without the unwanted effects the DH5α 
endotoxin would exhibit.  Propidium iodide staining found the plasmid posed very 
low-to-no toxicity on HeLa cells.  Mitochondrial staining using Mitotracker CMX 
Ros showed that the Hsp60-GFP was being taken up by mitochondria almost 
exclusively. High-glucose and sodium azide were used to stress the transfected 
HeLa cells and the translocation of the Hsp60-GFP signal was recorded using an 
Olympus FV1000 laser scanning confocal microscope.   
We found that the Hsp60-GFP colocalises with mitochondria to a high degree.  
We also found that high-glucose can be linked to the translocation of Hsp60-GFP 
out of mitochondria.  The results here support published data that suggest higher 
glucose concentrations may play a role in the translocation of Hsp60 out of 
mitochondria and into extracellular fluids.  We have also found that the use of 
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fluorescent-confocal microscopy may provide a useful way to detect the 
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1 Literature Review and Research Aims 
This chapter discusses the complicated disease Diabetes mellitus in relation to its 
biology and biochemistry.  Details are taken from current literature and provide 
insight into the degree of complexity that this disease employs.  The eukaryotic 
Hsp60 protein, implicated with Diabetes, is then reviewed followed by its primary 
host organelle, mitochondria.  Later, various experiments that have provided the 
basis for much of our own study are highlighted.  At the conclusion of this chapter 
our aims and objectives will be explained. 
      
1.1 Diabetes Mellitus 
1.1.1 The Diabetic Condition 
Diabetes mellitus affects more than 250 million people worldwide.  It is a 
pandemic disease affecting people from all countries, cultures and economic 
classes.  Diabetes, for most is an obstinate condition stunting the lives of those it 
inflicts and those who care for them.  It has been estimated that in 2007 the U.S. 
alone spent $116 billion treating diabetes and paying for concurrent patient care 
(Fowler 2010).  In New Zealand it was estimated that approximately 3.7% of 
individuals aged above 15 have diabetes.  This figure equates to approximately 
150,000 people.  The prevalence of diabetes differs between ethnic groups but 
universally increases with age (as high as 14.9% in European elderly) (Moore & 
Lunt 2000).  The figures increase every year as new cases are diagnosed.  The 
medical bill for the treatment and analysis of diabetic patients within the 
Counties-Manakau District was $66 million higher for diabetics than for non-
diabetics.  As the population increases, the incidence of diabetes may also 
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increase leading to more suffering and a larger bill for public health (Jackson et al. 
2009). 
Patients generally fall into one of two categories, those with type 1 diabetes and 
those with type 2 diabetes.  Type 1 diabetes occurs when an individual cannot 
produce enough insulin while type 2 diabetes occurs when an individual forms a 
level of insulin resistance (Fowler 2010).  Both types experience prolonged 
exposure to high concentrations of glucose in the blood and general circulation.  A 
higher concentration of blood-glucose is termed ‘hyperglycaemia’.  The World 
Health Organisation (WHO) has described diabetes based on hyperglycaemic 
values.  The fasting plasma glucose and 2-hour plasma glucose (2 hours after 
ingestion of 75 g glucose) levels found in healthy non-diabetics are values up to 
110 mg/dl (6.1 mM) and 140 mg/dl (<7.8 mM), respectively.  There are two 
stages of development between the non-diabetic and diabetic conditions.  The first 
stage is ‘impaired fasting glucose’ (IFG).  The IFG fasting plasma glucose level is 
from 110 to 125 mg/dl (6.1 to 6.9 mM).  The IFG 2-hour plasma glucose level are 
values up to 140 mg/dl (<7.8 mM).  The second stage is ‘impaired glucose 
tolerance’ (IGT).  The IGT fasting plasma glucose values are up to 126 mg/dl 
(<7.0 mM).  The IGT 2-hour plasma glucose level is between 140-200 mg/dl 
(≥7.8-<11.1 mM).  The fasting glucose level for Diabetes mellitus is above 126 
mg/dl (≥7.0 mM).  The 2-hour plasma glucose for diabetes is above 200 mg/dl 
(>11.1) (World Health Organisation 2006). 
The condition both types of diabetes have in common is a decrease in the 
biochemical efficiency of the insulin hormone leading to hyperglycaemia.  Insulin 
plays a role in the homeostasis of blood-glucose levels (Teuscher 2007).  In 
healthy individuals, insulin is produced in β-cells of the pancreas and is released 
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into the circulation upon detection of glucose from digestion through membrane 
bound GLUT-2 receptors (Stolarczyk et al. 2007).  The circulating insulin is 
targeted to insulin receptors on the cell membranes of adipocytes and striated 
muscle fibres.  This triggers the translocation of GLUT-4 receptors from the 
cytosol to the membrane.  Glucose can then enter through the GLUT-4 receptors 
and be processed for storage in glycogen molecules or catabolised to release its 
energy.  The primary targets of insulin are muscle and liver tissue, while other 
tissue can obtain the required amounts of glucose through other channels 
(Livingstone et al. 1995; Winzell & Ahren 2007).  The loss of insulin or a 
decrease in its effectiveness via degradation of itself or its receptors causes 
hyperglycaemia.  The resultant increase in glucose concentration can cause 
glucose to diffuse through cell membranes at an unhealthy rate causing stress to 
all cell types.  As pancreatic β-cells suffer during hyperglycaemia, decreases in 
their number exacerbate the insulin deficiency (Laybutt et al. 2002).  This is the 
reason many type 2 diabetics eventually become type 1 suffering from the type 1 
related β-cell loss.  Chronic hyperglycaemia causes demoralising conditions such 
as blindness, kidney failure and tissue breakdown which can lead to either 
amputation or death (Fowler 2010). 
The pancreas is an important organ of the human body which supplies enzymes 
for digestion and the hormones insulin and glucagon for glucose control.  The 
head of the pancreas articulates with the duodenum, where it connects through a 
duct.  The pancreas has been said to contain two different sections that are 
scattered throughout and in-between in a non-uniform pattern.  These two sections 
are called the exocrine and the endocrine.  The exocrine section contains the 
ability to produce digestive enzymes through its acinar cells.  The endocrine 
section is responsible for producing insulin via β-cells.  The type 1 diabetic 
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condition results from a lack of insulin being produced by diminishing β-cells.  
The type 2 diabetic condition is caused by insulin resistance which may be linked 
to inefficient production of insulin within the β-cells or a breakdown in glucose 
storage and management.  In healthy individuals the β-cells are arranged into 
islets within the pancreas that surround interlaced capillaries connecting cells to 
the circulation.  These islets are known as the islets of Langerhans and contain β-
cells alongside the closely related α-cells, δ-cells and PP-cells.  Though the β-cells 
make up most of the cellular component of these islets, the islets of Langerhans 
only equate to about 1-3% percent of the pancreas (Molina 2006). 
 
1.1.2 β-Islet Cell Loss in the Diabetic Pancreas 
After the pancreas has been compromised (due to injury or disease), or the β-cells 
have depleted, this insulin producing tissue is among the most difficult of tissues 
in the human body to grow in vivo.  The complexity of the events leading to the 
post-natal regeneration of β-islet cells has eluded researchers for decades (Slack 
1995).  Reversing the decrease in β-cell mass has been addressed in many studies 
using many different approaches.  Endogenous sources of β-cell renewal have 
included the manipulation of the transcription factor 3-Phosphoinositide-
dependent protein kinase 1 (PDK1).  PDK1 is an enzyme that is involved in 
intracellular signalling originating from hormones including insulin.  Its 
dysfunction results in cell death.  This enzyme was manipulated in order to 
understand premature apoptosis and improve the lifespan of β-cells within islets 
(Hashimoto et al. 2006).  Some researchers have approached dedifferentiation of 
pancreatic acinar cells and then the subsequent reprogramming of these to 
redifferentiate into the β-cell phenotype.  Different approaches have further 
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removed dedifferentiation steps using embryonic factors to bypass the long 
process and drive a phenotypic change from the neighbouring α-cells, δ-cells and 
PP-cells (all reside within the pancreas) (Tuch & Kannangara 2008).   
The addition of islet neogenesis associated protein (INGAP) has resulted in 
pancreatic β-cell growth in tests using murine models but has been questioned as 
to how these data may benefit humans, after similar INGAP tests on humans did 
not carry the same success (research using the homologous human proislet peptide 
(HIP) has yet to be completed) (Lipsett et al. 2007).  Techniques using transgenic 
mice has led to a greater understanding of the genes and proteins involved in β-
cell regulation (both mitotic and apoptotic) but has not helped in determining the 
controlling factors of β-cell demise in the adult population (Levine & Ilkin-Ansari 
2008; Tuch & Kannangara 2008).  The next few sections review in greater detail 
some of the work that has been done recently to understand β-cell loss and 
regeneration. 
 
1.1.2.1 β-Cell Loss Causes Hyperglycaemia  
Hashimoto et al. (2006) used murine models to create a system where β-cells were 
genetically altered to produce a phenotype lacking in 3-Phosphoinositide-
dependent protein kinase 1 (PDK1) from birth (β-cell-PDK1-/-).  PDK1 is an 
enzyme that is involved in intracellular signalling originating from exogenous 
hormones (including insulin) which upon elimination results in cell death (Mora 
et al. 2004).  The β-cell-PDK1-/- model was designed to highlight by deduction 
the importance of this gene (and subsequent protein) in β-cell subsistence, and 
consequently, the importance of β-cells in glucose homeostasis.  In situ 
hybridisation indicated that the PDK1 gene was successfully eliminated from the 
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β-cells while leaving other tissues uncompromised (PDK1+/+).  They found that 
all β-cell-PDK1-/- mice died within 6 months and that those kept under glucose 
control during that period showed excessive increases in blood glucose (above 
500 mg dl-1; healthy β-cell-PDK1+/+ controls stayed at approximately130 mg dl-
1).  The β-cell-PDK1-/- mice also showed declining levels of insulin (below half 
of the control levels within 4 months; almost undetectable within 6 months).  By 
compromising β-cells Hashimoto et al. (2006) showed that β-cell depletion causes 
reduced insulin levels and hyperglycaemia. 
On a similar note, Foxo1, a downstream target of PDK1, has been associated with 
diabetic symptoms in humans.  Studies on German and Finnish men showed 
correlations between certain Foxo1A mutations and altered insulin secretion and 
impaired glucose tolerance (Mussig et al. 2009).  Future research into this area 
may prove valuable for understanding the onset of diabetes in human patients 
(Maedler et al. 2006; Cnop et al. 2011).   
 
1.1.2.2 β-Cell Regeneration Research 
A simple stimulus for pancreatic growth was found in pancreatectomised mice.  
The mice had 90% of their pancreas removed and Bromodeoxyuridine (Brdu) was 
added to monitor the following pattern of growth for the remaining 10%.  Brdu is 
a uridine based nucleoside that can be introduced and incorporated into the DNA 
of proliferating cells.  Its incorporation can then be assessed using 
immunohistochemistry (Wojtowicz & Kee 2006).  A sham group which had 90% 
of its pancreas perturbed by rubbing was used to contrast the growth of the 
pancreatectomised group.  By day 3 the pancreas of the pancreatectomised mice 
had grown 195% (75% more than the sham group) and by day 6 the 
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pancreaectomised model had grown 261%, which was more than 100% higher 
than the sham model (145%).  The researchers observed a shifting occurrence of 
Brdu staining with time as the stain would diminish from earlier areas just as 
much as it increased in the newer areas.  After two days the growth had started in 
the common duct then moved into the growing regions within another day.  The 
growing regions housed the ductal branching and articulated with capillaries and 
connective tissue essentially growing a typical pancreas which included apparent 
islets of Langerhans.  This technique may indicate that β-cell islets may depend on 
signals governing the mass of the total pancreatic organ thereby adding to 
autoinhibition or downregulation of the growth of the β-cell component (Bonner-
Weir et al. 1993). 
The Reg (regenerating) family of proteins was established about two decades ago 
in studies on pancreatitis.  Reg proteins were known to be expressed during the 
disease and were believed to be responsible for regulating inflammation and 
reducing infection (Nata et al. 2006). 
Recent studies of the Reg gene found that increasing Reg protein synthesis within 
β-cells resulted in their regeneration ameliorating experimental diabetes.  By 
adding interleukin 6 (IL-6; an inflammation regulator) and dexamethasone (a 
synthetic steroid) researchers were able to induce the expression of Reg.  It was 
also found poly(ADP-ribose) polymerase (PARP; a protein involved in DNA 
repair and apoptosis) could deter the transcription of the Reg gene.  By adding 
PARP inhibiters in with the IL-6 and dexamethasone treatment, mRNA levels of 
Reg increased further, consequently improving β-cell growth (Akiyama et al. 
2001).  Islet neogenesis associated protein (INGAP), a RegIII protein (part of the 
Reg family), has been implicated as a major islet growth factor through 
stimulating the growth of β-cell mass in many individuals (and many species) 
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both diabetic and healthy (Lipsett et al. 2007).  PARP inhibiters used alone are 
believed to have therapeutic effects on diabetics.  The PARP inhibiters reduce the 
effects of hyperglycaemia by reducing the production of advanced glycation end-
products (AGEs) and reactive oxygen species (ROS).  Decreases in intracellular 
ROS can defer apoptosis and sustain healthier β-cell mass ratios (Brownlee 2005). 
Freund’s complete adjuvant (FCA; a mixture of oil, water and deactivated 
mycobacteria) has shown health improvements in diabetic KK-Ay mice (a murine 
strain highly susceptible to diabetes) (Muto et al. 1997) while others have used the 
same adjuvant to augment pancreatic tissue transplantation (Suri et al. 2006).  
Tests showed FCA significantly bolstered the return to glucose homeostasis in 
non-obese diabetic (NOD) mice after the transplants.  The direct health benefits 
were believed to originate from the immunity responses to FCA introduction.  
They recorded upregulation of immunity proteins such as interleukin 1 (IL-1; 
drives immunity response) which when upregulated by other means (not FCA) 
results in the same benefits (Suri et al. 2006). 
 
1.1.2.3 Stem Cell and Progenitor Cell Research 
Experiments studying the lineage of pancreatic cells have found evidence that 
pancreatic ductal cells can act as progenitor or stem cells for islets in neonatal 
models.  These progeny include β-cells, other endocrine cells and acinar cells (Xia 
et al. 2009).  The cause of islet regeneration in vivo has been in debate for some 
time with some arguments suggesting that cellular replication is primarily 
responsible, while others have suggested de novo islet generation from nearby 
progenitor cells.  Hanley and Rosenburg (2009) demonstrated that human islets 
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can be dedifferentiated into duct-like structures (indicative of pancreatic ducts) 
when treated with a peptide derivative of INGAP. 
Bar-Nur et al. (2011) developed four sets of pluripotency-induced β-cells (BiPSCs) 
to study the expression profile and efficiency of growing further β-cells.  Using 
pluripotent cells meant they could be used to grow any cell type from a single 
sourced cell, in this case a β-cell (Yu & Thomson 2008; Chan et al. 2009; Bar-
Nur et al. 2011).  They assessed the methylation status of the pancreatic and 
duodenal homeobox 1 (PDX1) gene.  The PDX1 gene encodes for an essential 
transcription factor required for β-cell maturation.  They noted that the degree of 
methylation was significantly lower than that found in non-beta pancreatic iPSCs. 
This was regarded as an artefact from the BiPSCs normal β-cell origin and 
demonstrated an advantage using BiPSCs for β-cell replacement therapies in 
patients.  Previous iPSCs experiments yielded lower β-cell production, making 
them inefficient for clinical use, so this BiPSC finding was thought of as a 
successful alternative to be explored (Bar-Nur et al. 2011). 
The potential for β-cell mass regeneration does not exclusively require the 
stimulation of stem cells within the gland.  Data have shown increasing evidence 
that future treatments may benefit by targeting the accompanying α-cells within 
the pancreas to either redifferentiate or evolve into β-cells to compensate for the 
loss.  Thorel et al. (2010) investigated the reported relationship between α-cells 
developing into β-cells via paired box 4 (Pax4) gene expression in mice. Pax4 is 
an essential gene involved in fetal development as well as pancreatic progenitor 
cell growth in adults (Sosa-Pineda et al. 1997).   After ablation of almost all β-cell 
mass (more than 99%) they observed a 3-fold increase in β-cell mass between 15 
to 30 days (using Pax4).  After 5 months of good treatment (maintaining 20 mM 
blood glucose) the mice had recovered enough to forgo any treatment.  Mice that 
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remained diabetic at this point still had a 10-fold increase in β-cell mass whereas 
recovered mice had a 44-fold increase.  Due to discrepancies in the predicted rate 
of β-cell regeneration and the appearance of actual β-cell mass they made the 
conclusion that most of the regeneration had come from a different source.  Using 
yellow fluorescent protein in new samples they performed lineage tracing of α-
cell replication after nearly complete β-cell ablation and found that a small 
proportion of α-cells (1-3%) had become bihormonal expressing both glucagon 
and insulin.  One month after ablation 65% of the β-cells had descended from α-
cells and most still retained substantial degrees of glucagon expression (Thorel et 
al. 2010). 
These observations support earlier work which used known embryonic pancreatic 
developmental factors Ngn3, Pdx1 and Mafa to induce mature pancreatic exocrine 
cells to develop a β-cell phenotype.  These induced cells began producing insulin 
(and C-peptide; an indicator in insulin production) within 3 days and ameliorated 
hyperglycaemia.  Despite the progress the manipulated cells failed to form islet 
structures.  This technique showed the possibility of avoiding dedifferentiation 
and redifferentiation to improve the efficiency of β-cell induction but the failure to 
form islets may highlight the importance of epigenetic memory (genetic 
conditions that can be inherited by progeny) (Zhou et al. 2008). 
Aristaless related homeobox (Arx) is an embryonic development gene involved in 
forebrain, testicular and pancreatic development (Gecz et al. 2006).  It was found 
that overexpression of Arx in β-cells could induce a characteristic change to α-
cells and pancreatic polypeptide cells (PP cells).  These cell types usually 
neighbour β-cells within pancreatic tissue and are derived from the same 
progenitor cells.  It was postulated that by manipulating the balance between Arx 
and Pax4, α-cells and PP cells could be used to source β-cells for patient therapy 
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(Collombat et al. 2007).  Further work by Collombat et al. (2009) demonstrated 
that the consistent expression of Pax4 could stimulate pancreatic cells to form β-
cell islets even to the detriment of having an absence of α-cells causing 
hypoglucagonemia and enlarged β-cell islets.  A key factor required in the 
pancreatic cell metamorphosis observed was the expression of Ngn3, an 
embryonic factor which has been seen to increase in expression in studies on 
pancreatic stem cell activation and progenitor differentiation (Collombat et al. 
2009). 
The multitude of evidence shows that β-cell loss can indeed be reversed, even 
though most of the data comes from experiments using animals other than humans.  
Strategies involving transplantation and other exogenous sources have been 
embraced by many people, and have given reasonable success but β-cell loss has 
remained an issue leading to the return of medicinal insulin treatment.  Besides β-
cell loss the lack of donors and immunosuppressant difficulties in humans 
continue to direct the need for research into endogenous systems of β-cell 
regeneration.  The stem cell induction approach has shown the most promise for 
future patients but remains a lifetime away from being an adequate answer for the 
diabetes pandemic as questions of efficiency and long-term side effects remain to 
be answered (Tuch & Kannangar 2008). 
The development of treatments which can control the growth and phenotype of 
cells in the pancreas and elsewhere in the body has been, and will remain, at the 
forefront of research into diabetes and other metabolic disorders.  In sight of a 
common goal, research must also be done into the biochemistry that governs cell 
plasticity and growth in order to gain an understanding of the metabolic memory 




1.1.3 Metabolic Consequences of Prolonged Hyperglycaemia 
A protracted experiment studying the effects of glucose exposure in diabetics has 
found that individuals who experienced periods of hyperglycaemia were more at 
risk of developing severe pathologies resulting from the high glucose 
concentration.  The intensity and duration of therapy given an individual affected 
the onset of pathology.  Those who were under intense glucose control were those 
whose blood-glucose levels were maintained to levels similar in non-diabetics 
while those who were under poor control experienced chronic hyperglycaemia.  
Individuals who were switched to an intensive control of glucose after a period of 
months of poor control showed a tendency to develop severe diabetes related 
pathologies (as detected by inflammation, ischemia and tissue breakdown) even 
after a long period of intensive control.  It was this unavoidable occurrence of 
pathology that led the researchers to coin the term ‘metabolic memory’ (Nathan et 
al. 2005). 
Various other tests have contributed to the overall understanding of the metabolic 
memory phenomenon.  The findings supported earlier studies which observed the 
same hyperglycaemic-induced recurrence of pathology after the reestablishment 
of glucose homeostasis.  Much of the diseases seen in individuals with prolonged 
diabetes have been well studied but an overall correlation with hyperglycaemia 
was never satisfactorily identified until the Diabetes Control and Complications 
Trial (DCCT) and the United Kingdom Prospective Diabetes Trial (UKPDS).  The 
DCCT and the EDIC (Epidemiology and Diabetes Complications; follow up to 
the DCCT) were large scaled tests which incorporated over 1,000 patients, 
searching for links between diet, diabetes and diabetic pathology.  Findings from 




Enduring chronic hyperglycaemia leads to increased advanced glycation end-
product (A.G.E. or AGE) formation, increased polyol and hexosamine pathway 
fluxes and an excess of activation of protein kinase C (PKC) isoforms.  These 
biochemical alterations induced by prolonged hyperglycaemia are some of the 
factors responsible for the apparent metabolic memory seen in diabetic 
pathologies (Browlee 2001).  These biochemical alterations, and others, will be 
discussed in the following sections. 
 
1.1.3.1 Metabolic Memory Causes Retinopathy  
In a study of the role of histone acetylation, Zhong and Kowluru (2010) 
performed an experiment using rats to determine whether histone acetylation 
could be contributing to the metabolic memory causing retinal pathogenesis.  One 
treatment group was kept in poor glycaemia control (PC), a second group was 
kept in good glycaemia control (GC; urine glucose below 150 mg/24 hr), with a 
third group kept in poor control for six months and then good control for another 
six months (PC-GC).  
The PC group was found to have significantly lower weight and higher glycated 
haemoglobin (GHb) values than the control group.  The GC group had similar 
weight and GHb levels to the control group.  The PC-GC group showed similar 
values to the PC group during poor control with their values becoming similar to a 
healthy control group after the initiation of good control.  In order to quantify 
histone acetylation, histone deacetylase (HDAC) and histone acetyltransferase 
(HAT) activity was measured from samples in each group.  As HDAC and HAT 
are directly involved in gene expression their quantification would help determine 
if a ‘memory’ had been created in the DNA of the PC-GC group (de Ruijter et al. 
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2003; Zhong & Kowoluru 2010).  In the PC group HDAC was three times higher 
with HDAC1, 2 and 8 being at least 70% higher than the control.  HAT activity 
decreased as inferred by the 30% (total acetylated histone 3 decreased 20-30%) 
decrease in histone 3 acetylation.  In the PC-GC group HDAC activity was 
increased along with HDAC1, 2 and 8 while HAT activity remained reduced 
presumably from the PC period.  The GC group showed limited increases in 
HDAC activity and HDAC expression and no decrease in HAT activity. 
The results from their experiment showed that even after six months of poor 
glycaemia control, six months of (recuperative) good control could not avert 
certain effects of prolonged hyperglycaemia (Zhong & Kowluru 2010). 
In a simultaneous study Kowluru et al. (2010) looked at the role of inflammation 
in the pathology of retinal pericyte loss due to metabolic memory.  Retinal 
pericytes are responsible for regulating blood flow through the capillaries that 
support the retina (Allt & Lawrenson 2001).  Bovine retinal pericytes were 
prepared from calves and randomly placed into one of three treatment groups.  
One group was assigned to 20 mM of glucose for two days followed by 5 mM 
(normal levels) of glucose for four days.  Another group was assigned four days 
of 20 mM glucose and then four days of 5 mM glucose.  The third group was put 
on 20 mM glucose for four days followed by 5 mM glucose for eight days.  
Between periods of glucose treatments the cells were rinsed and the media were 
changed often. 
To investigate the effect of dexamethasone (a synthetic steroid) inhibiting the 
intracellular proinflammatory process another group was incubated with 1 mM in 
the presence of 5 mM glucose for four days after a high 20 mM glucose four day 
period.  Appropriate controls were performed alongside the mentioned treatments.  
The results showed that pericytes incubated in 20 mM glucose for up to 4 days 
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had significant increases in all measured proinflammatory mediators from at least 
30%.  Cells incubated for four days of 5 mM glucose after two days of 20 mM 
show significant decreases in IL-1β, NF-κB, VEGF and TGF-β (cell proliferation 
proteins) expression and transcription while showing an increase in ICAM-1 
(immunity cell adhesion protein; needed for immune response) compared to the 
control.  The cells treated with four days of 20 mM showed that the following four 
days of normal glucose did not bring about any benefit and that all 
proinflammatory mediator levels remained high.   Extending the good glucose 
control period to eight days showed decreased levels in all but TGF-β but the 
other mediators were still well above normal.  Four days of 5 mM glucose after 
four days of 20 mM glucose failed to stop pericyte apoptosis but dexamethasone 
proved to be a powerful regulator of high glucose by inhibiting pericyte apoptosis 
and maintaining normal levels of VEGF and NF-κB even when incubated for 
eight days in 20 mM glucose (Kowluru et al. 2010). 
It is because of these experiments and many others that we now have an improved 
understanding of the epigenetic and metabolic memory which gives rise to the 
pathologies seen in diabetics (particularly Type 2 diabetics).  Hyperglycemia 
causes an influx of glucose derived metabolites which leads to AGE formation, 
intracellularly and extracellularly, and higher ROS production.  The AGE 
formation on mitochondrial proteins as well as strained glycolytic pathways 
causing excessive electron donation create the first half of a vicious loop ending 
with glyceraldehydes 3-dehydrogenase (GAPDH) inhibition.  GAPDH is 
important for the complete catabolises of glucose within cells (Nicholls et al. 
2012).  Its inhibition can cause unhealthy downstream effects.  The first by-
product of prolonged hyperglycaemia, AGE formation, will be discussed in detail 
next.   
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1.1.3.2 A.G.E. Formation Driven by Hyperglycaemia 
The hyperglycaemic cytosol facilitates an increased formation of glyoxal from the 
auto-oxidation of glucose.  This increase is a direct result of the unhealthy influx 
of glucose which the cell is not designed to accommodate.  It has been shown that 
the spontaneous nature of glyoxal formation increases within hyperglycaemic 
conditions (Thornalley et al. 1999).  Another product resulting from this glucose 
backlog is methlglyoxal (MGO).  MGO can be formed by the uncontrolled 
fragmentation of glceraldehyde-3-phosphate and dihydoxyacetone.  3-
deoxyglucosone is another glucose by-product that can be produced through 
passive, non-enzymatic pathways (Thornalley 1990 as cited by Brownlee 2001).  
In normal cellular conditions the glyoxalase system is responsible for processing 
glyoxal and MGO into less reactive products.  The glyoxalase system is 
comprised of two enzymes and reduced glutathione.  When the amount of MGO 
and glyoxal exceeds the activity of the glyoxalase system, much of these 
unprocessed substrates go on to adversely affect the cell (Xue et al. 2001).  
Aldehyde reductase has also been found to reduce AGE production in tests on 
PC12 cells from rats (by convert glucose to sorbitol, thereby reducing available 
glucose).  Hyperglycaemia can overwhelm these protective enzymes leading to 
more AGE production (Suzuki et al. 1998).  Much of the interaction that forms 
the resultant AGE products occurs through Maillard reactions (the non-enzymatic 
binding of sugars with amino acids in the presence of heat) (Reddy & Beyaz 
2006). 
Extracellular AGE is known to react with various matrix proteins such as collagen.  
AGEs can form cross-links between proteins in the matrix increasing stiffness.  
Sims et al. (1996) as cited by Beilin et al. (2001) described histological studies 
where AGE tissue accumulation and aortic stiffness were correlated.  There are 
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various receptors which ligand with AGEs, most notably RAGEs.  RAGEs, upon 
ligation can induce vascular lesions causing disease. 
Park et al. in 1998 studied the effects of a truncated RAGE receptor (sRAGE) in 
atherosclerosis.  ApoE-null mice (susceptible to atherosclerosis by way of a lipid 
transfer gene deletion) usually develop atherosclerosis earlier than their normal 
counterparts.  A group of these mice were diabetically induced with streptozotocin.  
Streptozotocin is a toxin similar in structure to glucose and as such the GLUT-2 
receptors on β-cells almost exclusively take in the toxin causing damage to the β-
cells (Szkudelski 2001; Bolzan & Bianchi 2002).  After six weeks of diabetes 
there were discrete lesions at common points in the thoracic aorta and aortic arch 
and had 5.3 times more area affected by lesions than the control. 
The diabetic group had a 2.3 fold increase in AGE from kidney extracts and a 2.5 
fold increase in plasma AGE than in the control group.  sRAGE was administered 
intraperitoneally once a day into hyperglycaemic mice and euglycemic mice.  
Another group received mouse serum albumin (MSA).  sRAGE treated diabetic 
ApoE-null mice had decreases in aortic lesion area and complexity relative to the 
doses received.  The diabetic mice treated 40 µg/day showed the same clear 
results as the non-diabetic mice treated with 40 µg/day MSA (both groups were 
ApoE-null).  It was suggested that introducing sRAGE into the vascular system 
may compete for binding with free AGE having an inhibitory effect (Park et al. 
1998). 
 
1.1.3.3 Biochemical Pathways Overloaded in Hyperglycaemia  
The polyol pathway flux has been implicated with various pathways to pathology 
in a cell.  The polyol pathway (non-flux) is involved in converting glucose into 
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sorbitol via the enzyme aldose reductase and then turning sorbitol into fructose via 
the enzyme sorbitol dehydrogenase (Lee & Chung 1999; Chung et al. 2003).  
Much of the connections between the flux and pathology have now been 
attributed to the excess activation of protein kinase C (PKC) which has its own 
pathways.  Aldose reductase converts glucose into sorbitol, with low affinity, 
using NADPH.  NADPH is used to reduce glutathione (GSH) by glutathione 
reductase.  It is the decrease in NADPH used by aldose reductase which brings 
about the decreased levels of GSH (Browlee 2001).  Sorbitol dehydrogenase turns 
sorbitol into fructose using NAD+ and turning it into NADH causing further 
channelling of glucose down the polyol pathway.  This loop exacerbates the GSH 
decrease causing potential oxdative stress to the cell and reducing its role as an 
antioxidant (Lee & Chung 1999). 
Hyperglycaemia can cause an increase in the flux of the hexosamine pathway.  
The pathway is incorporated into a sensing mechanism that triggers the synthesis 
of cell stress proteins (Hanover et al. 2010).  Having high glucose within the cell 
may cause the simultaneous production of glucosamine-6-P from fructose-6-P 
(instead of producing high fructose-1,6-bisP) by glutamine:fructose-6-phosphate 
amidotransferase (GFAT).  The excess glucosamine is then converted to N-
acetylglucosamine (GlcNAc) which is then attached by the O-GlcNAc transferase 
enzyme to transcription factors such as Sp1 as O-GlcNAc-Sp1.  The binding of 
glycosylated transcription factors is believed to generate more expression of their 
corresponding genes than normal phosphorylated transcription factors (Brownlee 
2001). 
An experiment on glucosamine concentration within mesangial cells (smooth 
muscle cells that regulate blood flow through the kidneys) showed that low 
concentrations allowed the cells to proliferate but that higher glucosamine 
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concentrations induced increases in proapoptotic proteins.  An amount of 
glucosamine (10 mM) administered for four hours showed a three to four fold 
increase in p53 (which regulates many genes including proapoptotic genes) which 
was sustained for eight hours.  Other proapoptotic changes were observed with 
increased levels of Bax and decreased levels of Bcl-2 (Le et al. 2010).  
 
1.1.3.4 Excessive PKC Activation by Hyperglycaemia 
Hyperglycemia can increase the production of diacylglycerols (DAG) from 
glycerol-3-phosphate, which is produced from dihydroxyacetone phosphate.  This 
increase in DAG activates nine of the enzymes in the PKC family (Assert et al. 
2001; Lori et al. 2003).  Activated PKC-beta and delta isoforms increase NADPH 
oxidase activity leading to increased ROS production.  NADPH oxidase is an 
enzyme that uses reduced nicotinamide adenine dinucleotide phosphate (NADPH) 
to bind with oxygen to form superoxide, one of the ROS species (Bedard & 
Krause 2007). 
Further capillary occlusion coupled with AGE formation can be due to increased 
PKC giving rise to increased TGF-β.  It is through increased TGF-β that an 
increase in collagen and fibronectin can occlude capillary blood flow (Brownlee 
2001).  An experiment researching the effects of a PKC beta inhibitor in diabetic 
db/db mice showed promising therapeutic properties for the inhibitor.  The db/db 
mice had a 400% increase in mesangial extra cellular matrix (ECM) contributed 
largely by fibronectin and type IV collagen.  Subjects treated with the inhibitor 
had approximately half the mesangial area than subjects not treated showing 
evidence that PKC beta is involved in the overexpression of proteins for the ECM.  
Increased TGF-β expression was observed in the glomeruli of the db/db mice.  
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This expression was attenuated along with excessive ECM area in subjects treated 
with the PKC-beta inhibitor (Koya 2000). 
 
1.1.3.5 ROS Production Due to Hyperglycaemia 
Du et al. (2003) have performed many experiments providing an abundance of 
data, about the role of ROS and diabetic pathology.  They treated bovine aortic 
endothelial cells with different treatments, two in particular, 5 mM glucose or 30 
mM glucose.  The cells with 5 mM glucose were used to simulate normal 
glycemic conditions while the 30 mM glucose was used to simulate diabetic 
conditions.  GADPH activity in the 30 mM group was highly inactivated, as is 
believed to occur in diabetics in vivo.  Normal GAPDH activity was observed in 
the group treated with 5 mM glucose. 
Another group treated with 5 mM glucose and a GAPDH inhibitor (GAPDH 
antisense oligonucleotides) showed similar GAPDH inactivity to the 30 mM 
group.  This evidenced the understanding that GAPDH can be regulated by 
glucose levels.  They further found that GAPDH inhibited 5 mM cells expressed 
approximately the same increased levels of PKC activation, intracellular AGE 
formation and nuclear factor kappa-light-chain enhancer activated of B cells (NF-
κB) activation as the 30 mM group.  NF-κB is responsible for activating many cell 
stress response genes (Li & Stark 2002).  Its activation is indicative that the 
endothelial cells were under stress during exposure to hyperglycaemia. These 
findings further supported GAPDH as being glucose regulated.  They inhibited 
poly(ADP-ribose) polymerase (PARP) and observed a correlation in continued 
GAPDH activity in 30 mM cells which showed the opposite level of activity to 
GAPDH in normal PARP 30 mM cells (Du et al. 2003). 
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1.1.3.6 Glycation of Mitochondrial Proteins 
It is believed that an increase in cellular glucose saturates the electron transport 
chain (ETC) with electron donors from the citric acid cycle (TCA).  The 
saturation of the ETC unbalances the electrochemical potential allowing for 
prolonged existence of intermediates (ubisemiquinone etc.) which gives rise to 
ROS.  As this perturbed ETC system continues to produce ROS the levels of ROS 
escape the super oxide dismutases and cause damage to the DNA.  Poly (ADP-
ribose) polymerase (PARP) is activated by this DNA damage and uses NAD+ to 
create nicotinic acid and ADP-ribose.  Excessive amounts of ADP-ribose cause 
some to bind to GAPDH inactivating it.  Inactivated GAPDH gives rise to further 
increases in ROS via a backup of glycolytic metabolites.  High glyceraldehydes-3-
P contributes to increased PKC activation and MGO production which causes 
AGEs.  High fructose-6-P contributes to the increased hexosamine pathway flux 
and high glucose contributes to the increased polyol pathway flux.  This is the 
vicious cycle created by excessive glucose which causes much of the pathogenesis 
in diabetes (Brownlee 2005). 
Rosca et al. (2005) studied the effects of glycation of mitochondrial proteins.  
They extracted mitochondria from the kidneys of Lewis rats which had been 
diabetically induced and kept in pathogen-free conditions.  Appropriate controls 
were set up.  The mitochondria was subjected to several experiments looking at 
glycaemia control, oxidative stress, carbonyl-induced modification of 
mitochondrial proteins and the effects of aminoguanidine on compromised ETC. 
They observed the usual hyperglycaemic symptoms of higher Hb glycation in 
streptozotocin induced diabetic rats than the controls.  After 12 months the 
mitochondria from diabetic rats experienced significant inhibition of state 3 
respiratory activity and increased state 4 activity.  A NADH oxidase assay tested 
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the integrity of the ETC.  The ETC was significantly inhibited by 19% after 12 
months of diabetes.  They further investigated the ETC components to find that 
Complex III was the primary effected component in the ETC by hyperglycaemia. 
Inhibition or interference with Complex III is thought to increase the output of 
ETC derived ROS by prolonged exposure of ubisemiquinone to oxygen.  The 
research team then diverted to discovering whether there had been earlier 
mitochondrial protein modification putatively caused by hyperglycaemia.  
Western blotting and immunoprecipitation revealed that two of the eleven 
Complex III components are modified by MGO (AGE formation).  
Aminoguanidine (a drug used to inhibit AGE formation from 3-deoxyglucosone 
(Nilson 1999)) administration decreased the MGO-induced modifications (Rosca 
et al. 2005). 
The onset of a metabolic memory, in cases of diabetes, is believed to be driven 
primarily by a build-up of glucose in the circulation.  The methods where this 
build-up occurs can be different, but after long periods of suffering the end result 
of this build-up is the same.  The deposition of AGE products, and the constant 
release of ROS in the system causes stress to the tissue and affects the individual 
cells.  In response the cells undergo programmed cell death, or apoptosis, which is 
evident in cases of retinopathy and pancreatitis where cellular breakdown has 
caused organ dysfunction (Kowluru 2010; Zhong & Kowluru 2010).  
In order to appreciate the contribution that cellular breakdown plays in diabetes 
we must understand the role that apoptosis and programmed cell death play in 
regulating tissue growth.  Controlled cellular breakdown is as important as 
cellular growth.  This system ensures the avoidance of constant tumours and 
unnecessary biomass in healthy individuals.   
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1.1.4 Apoptosis and Programmed Cell Death 
The word apoptosis is used to describe the organised breakdown and loss of cells.  
It is sometimes used variably with the term ‘programmed cell death’ coined by 
Lockshin and Williams (1964: as quoted in Pearce 2008).  Early research into 
biological systems witnessed the occurrence of cell growth and proliferation while 
recording the occurrence of organised cell loss.  This cell loss was initially 
thought to be controlled by necrotic events but overtime and by the assistance of 
ever-increasingly powerful technology, it became more evident that cell loss was 
being controlled not just by necrosis but by innately-programmed biological 
pathways (Kerr et al. 1972).  Apoptosis is now understood to be a part of a larger 
scheme of cell regulation that occurs in developing animals as well as their aged 
counterparts.  This regulation occurs alongside mitosis (cell growth by dividing) 
to bring about the precise organisms living today (Elmore 2007). 
A robust model of apoptosis was devised using the nematode Caenorhabditis 
elegans.  Due to its ease of cultivation and simple cell structure (1,090 cells in 
hermaphrodites; 1,179 cells in males) C. elegans provided a simple platform 
where cell growth could be monitored alongside developmental apoptosis.  The 
number of cells that undergo programmed cell death (131 cells in hermaphrodites; 
148 cells in males) during the organism’s development was also an easier task 
comparative to more complex organisms.  Researchers found that at least 13 
genes were associated with the apoptotic events and that most of these had 
conserved homologues to more complex species including humans (Horvitz 1999). 
Three major pathways have been described that can initiate programmed cell 
death, each of which lead to the activation of pro-apoptotic caspases.  The 
perforin/granzyme pathway is used by cytotoxic T cells and natural killer (NK) 
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cells to target other neighbouring cells for apoptosis.  The perforin protein binds 
and inserts into the target membrane forming oligomeric pores that allow the next 
piece of the pathway, granzyme, to pass through into the cytosol of the target cell 
(Law et al. 2010).  Granzyme A activates the SET complex (a group of proteins 
containing the ‘SET’ protein that are involved in DNA cleavage), which then 
brings about DNA cleavage via the release of DNase NM23-H1 while granzyme 
B activates caspase 3 and caspase 10 (Fan et al. 2003).  The extrinsic pathway 
relies on the ligand-activation of target cell-surface death receptors.  There are 
multiple receptors identified but some better understood versions are FasR and 
TNFR1.  FasR binding immediately recruits Fas-associated protein with death 
domain (FADD) while TNFR1 binding recruits tumour necrosis factor type 1-
associated death domain (TRADD), FADD and RIP (a protein kinase needed for 
apoptosis (Barcia et al. 2003)).  These factors come together to produce the death 
inducing-signalling complex (DISC) which with procaspase-8 triggers activity of 
caspase 3.  Activated caspase 3 is a master switch for apoptosis (Kischkel et al. 
1995).  The last pathway is the intrinsic pathway.  Cellular stress from invasive 
chemicals, such as toxins and ROS, as well as conditions like hypoxia, brings 
about mitochondrial stress.  The release of cytochrome c from stressed 
mitochondria into the cytosol forms the apoptosome with Apaf1 and procaspase-9.  
The apoptosome then activates caspase 3 (similar to the extrinsic pathway) which 
is a key switch in committing the cell to undergo apoptosis (Elmore 2007).  
Cells can endure different types of stress for varying periods.  It has been found 
that the Hsp60 protein can be released by these cells as a potential indicator of 
stress.  Elevated levels of Hsp60 have been found in diabetic patients (Devaraj et 
al. 2009; Yuan et al. 2011) and it is thought that this quandary may provide 
pivotal information to understanding the prevalence of tissue breakdown in 
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diabetes.  By first understanding Hsp60 we may make better judgements about its 
role in diabetes. 
 
1.2 Heat Shock Protein 60 
1.2.1 Biological Importance of Hsp60 
Hsp60 is a 60 kD protein most often found within healthy mitochondria.  As a 
member of the chaperonin family it is involved with the transportation of 
polypeptides originating from the cytosol into the mitochondrial matrix.  It is 
further involved with the successful folding of those same polypeptides into their 
tertiary states.  Hsp60 is not only found in the mitochondria but as a functioning 
protein in the cytosol as well, acting as a chaperone and partner in other reactions 
(Gupta & Knowlton 2005; Quintana & Cohen 2011). 
The Hsp60 protein has at least 150 homologues in various species including some 
that closely describe our world’s biological origins such as archea.  Many of these 
homologues are between 40 to 100% conserved in amino acid sequence similarity 
(Brocchieri L & Karlin S 2000).  The most commonly studied homologue to 
human Hsp60 is GroEL from E. coli strains.  In early research GroEL was 
characterised by studies that analysed the synthesis of bacteriophages in E. coli 
colonies.  By adding inhibitive mutations to the genes for GroEL and GroES 
(Hsp10 homologue) the bacteriophages were not synthesised leading researchers 
to postulate that GroEL and GroES were important factors in protein synthesis.  
Further research showed these same mutations rendered the cells incompatible 
with heat stress at 42
o
C (Zeilstra-Ryalls et al. 1991).  Later research on GroEL 
showed that translated polypeptides, for a number of essential proteins, as well as 
the non-bacterial human ornithine transcarbamylase (OTC) protein failed to fold 
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into their tertiary states when the mutant GroEL was rendered useless by heat 
shock (using a mutant GroEL produced with heat sensitive mutations).  The 
polypeptides were instead found to fold spontaneously into other forms or 
aggregate and precipitate (Horwich et al. 1993; Fenton et al. 1994). 
As evolution had already indicated the immense importance of Hsp60 it has been 
found that a number of diseases that affect the human condition have been linked 
to deficiencies in this chaperone.  Several mutations to the HSPD1 gene encoding 
human mitochondrial Hsp60 (mitoHsp60) have been linked to hypomyelination 
and concomitant neurodegenerative disorders (Magen et al. 2008).  Deletions and 
substitutions of various amino acids in the mitoHsp60 protein have proven 
overwhelming to the health of the hosts’ mitochondria.  A missense mutation, 
D29G, is implicated with a complicated spastic paraplegia (SPG) while a V89I 
mutation leads to (SPG13), a latent version of the disease with high penetrance.  It 
has been postulated that patients that live with these allelic mutations subsist on 
the mitoHsp60 produce by the alternate allele ergo suffering from 
hypomyelination (Magen et al. 2008). 
 
1.2.2 Hsp60 Form and Function 
In order for these Hsp60 related processes to take place, the Hsp60 must first be 
incorporated into a 14 member oligomer consisting of identical Hsp60 proteins.  
The complex forms in the shape of two rings.  Both rings contain seven proteins 
and these rings bind together to form the cylindrical quaternary structure.  This 
quaternary complex was initially named GroEL after its characterisation in E. coli 
and dominates the titles of past research into chaperonins.  This Hsp60 complex, 
hereafter referred to as chaperonin60, is still not complete without the partnership 
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of Hsp10.  Hsp10 forms a polymer from seven identical proteins which has been 
described as a cap that articulates with the quaternary Hsp60 complex.  Like 
GroEL, the initial name given for the seven member complex was GroES in E. 
coli hereafter referred to as chaperonin10 (Horwich et al. 2007).  Three domains 
have been described in the chaperonin60 structure, each being distinct in function 
from the other domains.  The apical domain houses the binding sites for substrates 
and the chaperonin10 cap.  The intermediate domain provides flexibility to the 
complex needed during the binding of ATP.  The equatorial domain provides the 
site for ATP binding and as indicated by its name provides the articulation sites 
for binding with the partnering ring structure to form the quaternary chaperonin60.  
During the chaperonin60s hydrophobic-surface state a polypeptide substrate can 
bind to the apical domain via a hydrophobic groove between two helices, H and I.  
ATP then binds to the equatorial domain changing the chaperonin60 conformation 
which in turn changes the hydrophobic-surface state to a hydrophilic one.  This 
releases the polypeptide into the chaperonin cavity while also priming the apical 
domain to bind with chaperonin10.  Inside the cavity hydrophobic and hydrophilic 
interactions between the polypeptide and the chaperonin play a role in 
accommodating the desired folding.  As ATP is turned to ADP chaperonin10 is 
also released and the newly folded protein is released into the intracellular space 
(Feltham & Gierasch 2000; Ranford et al. 2000; Horwich et al. 2007).  Due to the 
serious requirement for cells to produce viable proteins functioning in the correct 
location Hsp60 is one of the most conserved genes in evolution. 
Hsp60 is one of several proteins that form the heat shock protein family.  Like 
other heat shock proteins (Hsps) Hsp60 can assist in protein folding and 
chaperoning of the protein structures to maintain their stability within cells.  Heat 
shock treatment causes increased expression of Hsps which has been used to 
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demonstrate the arrest of cellular apoptosis after mild heat shock (Calderwood et 
al. 2007).  Other forms of stress can cause increases in the expression of Hsps, 
many of which have yet to be elucidated. 
The Hsp60 protein has been the focus of some ‘chicken and egg’ research in the 
past.  Cheng et al. (1990) used a mif4 yeast strain containing a temperature-
sensitive Hsp60 to determine if introduced wild-type Hsp60 could rescue the heat 
stressed cells from inhibition and death.  At 37
o
C the growth of mif4 is inhibited 
and can only be redeemed if the temperature is lowered to 23
o
C within 6 hours.  
By growing the mif4 at 37
o
C they found that the only cells growing were 
transfected mif4 (containing the wild-type Hsp60) (Cheng et al. 1990).   
 
1.2.3 Hsp60/Caspase Mediated Apoptosis 
Hsp60 has been shown to form a sequestration complex with the pro-apoptotic 
protein Bax in the cytosol of cardiomyocytes.  This has been confirmed by 
electron paramagnetic resonance (EPR) and immune-electron microscopy which 
have shown a colocalisation of the two proteins while others have also observed 
the anti-apoptotic Bcl-XL protein colocalising with Hsp60.  Experiments testing 
the effects of cellular stress due to hypoxia or by decreasing the amount of cellular 
ATP (similar end-result to hypoxia) have shown translocation of Hsp60 to the 
plasma membrane and the concomitant translocation of Bax to the mitochondria.  
The molecular reason for the division between Hsp60 and Bax is not fully 
understood but dose dependant administration of antisense Hsp60 has further 
confirmed that reductions in Hsp60 lead to increased degradation of Bcl-XL and 
increased synthesis of Bax.  Administration of Hsp60 to previously Bax 
administered cells also inhibits apoptosis.  Bax proteins form oligomers which 
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install into the mitochondrial membranes as pores.  Any free cytochrome c can 
then leech out through these pores into the cytosol and combine with Apaf-1 and 
caspase 9 to form the apoptosome.  This then stimulates caspase activity ensuring 
the apoptotic determination of the cell (Gupta & Knowlton 2005).  Hsp60 has 
been implicated as a target of the autoimmune response seen in β-cells.  The 
transgenically induced expression of an auto immune-sensitive Hsp60 epitope in 
the thymus reduced the occurrence of diabetes in NOD mice from 76% to 27%.  
In normal individuals it is thought that T-cells target specific Hsp60 epitopes that 
are expressed on the surface of the β-cells while tolerating the expression of many 
other Hps60 epitopes expressed in other tissues (Birk et al. 1996). 
 
1.2.4 Extracellular Hsp60 Activity 
Ghosh et al. (2008) demonstrated that elevated levels of Hsp60 can be found in 
adenocarcinoma cells of human breast and colon tissue.  By using interfering 
siRNA designed to ablate Hsp60 (both the cytoplasmic and mitochondrial) they 
observed a decrease in the amount of the IAP (inhibitor of apoptosis) family 
protein survivin that could be extracted using western blots.  This decrease in 
survivin is thought to be evidence contributing to a theory that Hsp60 actively 
sequests survivin protein in ‘pools’ within mitochondria that allow for survivins 
quick release to inhibit apoptosis in times of cellular stress.  The cytoplasmic 
survivin is understood to prevent the activation of caspase-9 by binding with it 
inherently reducing caspase-9s binding with the apoptosome (Dohi et al. 2004).  
Within healthy cells this role is an acceptable occurrence prolonging cellular 
viability whereas in cancer cells the increased Hsp60 my actually help propagate 
cancerous growth by unnecessarily halting apoptosis.  Further research in the 
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same study by Ghosh et al. (2008) showed that the ablation of Hsp60 correlated 
with an increase in p53 expression which is thought to induce Bax related 
apoptosis.  By regulating the levels of Hsp60 in the tumours of cancer patients it is 
postulated that the tumour regulating proteins described can be reinstated to their 
normal healthy roles.   
The term ‘metabolic memory’ has been used to describe the state of vascular 
breakdown occurring in long-time diabetic patients.  The major contributing 
attribute of patients with apparent metabolic memory is hyperglycaemia which 
can be brought about by a prolonged high glucose diet, insulin resistance or β-cell 
deficiency.  Higher levels of blood-serum Hsp60 have been observed in most 
cases of the disease and when considering the latest research into Hsp60 and 
inflammation, it becomes clear that an understanding of Hsp60s role in potentially 
propagating diabetes needs to be specifically investigated (Jax 2010).  A recent 
clinical study has highlighted the state of serum Hsp60 and anti-Hsp60 expression 
in diabetic patients before and after intensive glycaemic control.  Researchers 
found that despite seeing significantly reduced glycosylated haemoglobin, and 
decreases in BMI (body mass index), waist circumference and HOMA 
(homeostatic model assessment) figures, the levels of serum Hsp60 and serum 
anti-Hsp60 did not change.  Even the levels of variance in Hsp60 sampling 
showed little change.  A significant decrease in IL-6 was also recorded suggesting 
a small, potential decrease in inflammation but the levels of IL-8, IL-10, IL-12 
and TNFα were unchanged.  This observation may add to our understanding of 
the correlation between Hsp60 and metabolic memory (Blasi et al. 2012). 
A study on children suffering from clinically diagnosed septic shock (a whole 
body inflammatory disease due to microbial infection) used ELISA techniques to 
investigate the levels of Hsp60 in the blood serum of 63 children suffering from 
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sepsis, 10 critically ill children not suffering from sepsis, and 24 healthy control 
children.  They found that 24 hours after entry those with sepsis had significantly 
higher amounts of serum Hsp60 than those who were compromised with other 
illnesses.  This was also apparent when comparing the sepsis patients with the 
healthy controls.  The median Hsp60 levels in sepsis patients were 16.7 ng/ml 
whereas the levels in the other groups were 0 ng/ml (Wheeler et al. 2007). 
Hsp60 has been well characterised as an important factor in many types of heart 
disease.  Patients suffering from arterial fibrillation (irregular heart beat) were 
compared with healthy controls with regular heart beats (sinus rhythm).  The 
researchers used samples of myocardial cell samples excised from the right atria 
in patients undergoing cardiac surgeries and found that the levels of Hsp60 were 
significantly higher with a 2.5-fold increase in patients with arterial fibrillation 
(Shafler et al. 2002).  Earlier work on the hearts of patients suffering from dilated 
cardialmyopathy (DCM) showed similar patterns of increased Hsp60 expression 
in stressed cells excised from hearts during surgeries.  They witnessed a 5-fold 
increase Hsp60 expression in tissue with DCM than the healthy donor hearts.  
Another observation recorded by the researchers was that the DCM heart samples 
contained much higher development of type I and III collagen in the form of 
fibrosis, another indicator of substantial tissue stress (Latif et al. 1999).   Studies 
on murine hearts have illustrated well the movement of Hsp60 from intracellular 
locations to the surface of stressed myocytes.  From nine to twelve weeks after 
LAD ligation of the rat hearts, data showed localisation of Hsp60 to the 
membrane of cells, with some treated samples having Hsp60 on the outside 
surface of the membranes.  TNF-α, LVDD, BNP and ANP were increased 
confirming high levels of stress and the propagation of inflammation.  By using 
fluorescently labelled indicators that bind to caspase 3, 7 and 8 that fluoresce 
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during caspase activation the researchers observed that in cells with Hsp60 
localising to the membrane also had a correlated increase in caspase 3, 7 and 8 
activation.  By using propidium iodide to stain for ruptured membranes they 
found that cells with membrane located Hsp60 had no greater inclination to accept 
the PI stain than other cells without the same Hsp60 profile, indicating that the 
localisation of the Hsp60 to the membrane correlated well with apoptotic events in 
those respective cells (Lin et al. 2007; Knowlton & Uma 2008). 
Hsp60 has been found to hold extracellular roles differing from the protein-
chaperoning it is primarily responsible for inside host cells.  Recent research from 
the past decade has given evidence that Hsp60 is an important node in the immune 
network.  Research into monocytes and dendritic cells has revealed that Hsp60 
present in the corresponding media can cause these innate immunity cells to 
mature and activate their immune responses.  This can result in the release of 
various pro-inflammatory molecules such as IL-1β, IL-6, IL-12, IL-15 and TNFα 
into the extracellular space (Henderson et al. 2010; Quintana & Cohen 2011).  
Hsp60 has also been found to interact with B cells and T cells.  Cohen-Sfady et al. 
(2005) used murine B cells to test the immunicological interactivity of human 
Hsp60.  They found that dose dependant exposure to Hsp60 could be correlated 
with respective increases in B cell proliferation, a consequence not seen before in 
other immune cells exposed to Hsp60.  B cells also released a differing profile of 
cytokines to other immune cells.  These B cells were secreting higher levels of IL-
10 and lower levels of IL-6.  Once placed in the presence of T cells the B cells 
drove the T cells to release IFN-ϒ and IL-10.  By comparing B cells between 
wild-type, mutant TLR4 receptor and knockout MyD88 (myeloid differentiation 
primary response gene) cell variants it was deduced that Hsp60 interaction with B 




1.3.1 The Mitochondrial Organelle 
Mitochondria are eukaryotic cell organelles that are responsible for the production 
of ATP energy within their host cells.  Mitochondria range from 0.5 µm to 1 µm 
in size and are believed to be derived from a symbiosis between ancient 
eukaryotic and bacterial cells.  This relationship has landed mitochondria with 
many roles in cellular growth, adaptation and death.  Mitochondria have retained a 
small amount of DNA where genes for a variety cellular growth and regulation 
genes can be found.  Most important genes for growth and adaptation still reside 
within the cells’ chromosomes.  As such, the analysis of mitochondria has become 
a means of understanding this observed cell plasticity under stress, and a means of 
analysis of programmed cell death (Henze et al. 2003). 
 
1.3.2 Mitochondria and Hsp60 in Disease 
By comparing the expression and profile of Hsp60 and mitochondria researchers 
have ascertained ways to understand and predict stress under certain conditions.  
Hsp60 has been found useful in predicting the onset of desired apoptosis in 
tumours in human bladders.  The usefulness of Hsp60 expression analysis 
exceeded that of p53 analysis, the next trigger in the apoptotic pathway, much 
closer kinetically to the apoptotic event.  By improving the awareness of Hsp60 
expression future patients needing chemoradiotherapy to treat the cancer may be 
better managed, avoiding excessive exposure to the aggressive treatment 
(Urushibara et al. 2007).  A study on murine myocytes used an adenoviral vector 
incorporated with Hsp60 and Hsp10 (AdvHsp60 and AdvHsp10) to increase the 
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said proteins’ expression in the host cells’ mitochondria.  It was found that during 
ischemia and reperfusion cells with increased levels of AdvHsp60 and AdvHsp10 
were able to avoid apoptosis by 40% compared to the controls.  The 
overexpressing cells were also better maintained during reoxygenation having 
mildly lower caspase-3 activation initially but substantially lower activation after 
4 hours.  These data provide a means to use and develop Hsp60 clinically to 
improve patients’ outcomes after physically stressful injuries (Lin et al. 2001). 
In order to develop protocols for medical professionals to diagnose and assess 
patients suffering from diabetes and metabolically related diseases more research 
needs to be completed into using Hsp60 as a marker for cellular stress.  
Transfection of cells offers an effective way to introduce fluorescently labelled 
Hsp60 and other genetic information into living eukaryotic cell lines.  The 
labelled Hsp60 can then be followed using fluorescence microscopy to ascertain 
the degree of stress that certain conditions produce. 
 
1.4 Cell Transfection 
1.4.1 Various Transfection Events 
The term transfection describes a procedure where foreign genetic material is 
introduced into a living eukaryotic cell.  As a result of differing parameters such 
as cell type, transfection method and environmental condition, the transfection 
protocols implemented in different experiments can be very disparate.  The 
physiological results of the introduced nucleic acids may also play an important 




Stable transfections are performed when introduced nucleic acid is incorporated 
into the chromosomes of the host cell.  This incorporation requires that the genes 
encoding new mRNA be accompanied by selection markers such as specific-drug 
resistance genes.  After one to three days the original cell media is replaced by 
selective media.  Approximately two to three days after this exchange the 
remaining culture growing in the presence of the stressor drug is believed to be 
due to cells that have incorporated the foreign nucleic acids into their 
chromosome (Recillas-Targa 2006). 
Transient transfections are performed when introduced nucleic acid is brought 
into regions of the cell that allow for the processing and transcription of the 
genetic code.  Cells can be successfully transfected (transiently) by introducing 
mRNA into the cell cytosol.  mRNA located in the cytosol can be directly 
translated by the host ribosomes into the concluding protein.  Transient 
transfection with DNA requires the foreign DNA to be brought into the host cells 
nucleus where it can be processed and transcribed by the host cells transcription 
apparatus.  Transient transfections may last from 1 to 3 days in common cases 
before the genetic material is lost (Recillas-Targa 2006). 
 
1.4.2 Transfection Methods 
There are many transfection protocols used which have inherent advantages and 
disadvantages dependant on the cell type, time and cost involved.  The calcium 
phosphate method is comparatively cheaper than any other approach.  It relies on 
the binding between molecules of calcium phosphate and adsorbing DNA 
molecules in the transfection solution.  The method of DNA uptake by the cells is 
not fully understood but endocytosis and phagocytosis of the calcium phosphate-
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DNA complex are thought to be possible pathways for the DNA uptake.  A 
disadvantage of relying solely on chemical methods is that transfection 
efficiencies can be as low as 1% in certain cell lines (Jordan et al. 1996; Salozhin 
& Bolshakov 2009). 
A similar method to the use of calcium phosphate includes the cationic lipid 
driven lipofection.  Despite the differing names and structures of these lipid 
agents they all have similar elements that characterise the fundamental quality of 
transfection lipids.  They have a positively charged head group which interacts 
electrostatically with the negatively charged sugar-phosphate backbone on the 
nucleic acid.  The lipid molecules themselves can interact together to form 
approximately 100 nm liposomes which, being positively charged, migrate 
towards the negatively charged cell membranes. It is believed that the complex is 
taken up by similar means seen with other chemical transfection reagents such as 
calcium phosphate.  The pathway from the cytosol to the nucleus remains elusive 
but it is postulated that the entire lipid-DNA complex may be brought into the 
nucleus where the nucleic acid is then processed.  Despite the improvement in 
transfection efficiency when compared to non-lipid reagents the same 
disadvantage remains for certain cell types that still produced as little as 1% 
transfection efficiency.   Lipofectamine 2000 is among the most commonly used 
lipofection agents available (Dalby et al. 2004). 
Physical methods for transfection have been increasingly popular overtime as the 
technologies that govern these protocols have become more refined.  There are 
many different physical approaches that omit cationic molecules and biological 
vectors and still achieve substantial transfection efficiency.  A major dividing 
factor between these approaches is whether the protocol is predominantly 
mechanical or physical in nature.  Mechanical protocols can use either 
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microinjection or ‘gene-gun’ apparatus.  Microinjections have been known to 
produce nearly 100% transfection efficiency in target cells (Zhang & Yu 2008).  
Though the advantages are obvious the disadvantages include labour intensive 
single-filed cell manipulation.  To achieve a maximal outcome requires 
consistency and copious amounts of time, even after the cost of the apparatus has 
been considered.  The gene-gun or ‘biolistic’ approach is similar in demand for 
financial investment but has a wider application.  Shallow cell cultures or tissue 
surfaces are the limit to the current generation of devices but are sufficient to 
warrant the use of the gene-guns for many research applications and topical 
treatments on patients.  A comparative study showed slightly higher transfection 
efficiencies for gene-gun transfections than transfections performed using 
Lipofectamine 2000 on mammalian cells (Uchida et al. 2009). 
Predominantly physical protocols include electroporation, sonoporation and laser 
irradiation.  Electroporation and sonoporation rely on the same premise that 
pulsating cells with electricity or ultrasound can cause a disruption in the cell 
membrane resulting in pores that allows the DNA to diffuse in with or without aid 
from chemical reagents.  Laser irradiation, or ‘phototransfection’, has shown 
much promise in recent years.  The protocol requires the pulsation of a cell 
membrane with a laser for as short as one femtosecond that can create a pore large 
enough for the DNA to diffuse into.  The transfection efficiency has been seen as 
high as 100% (Tirlapur & Konig 2002).  The other advantage to using laser 
irradiation is that sections of cells can be targeted specifically, so in the case of 
neuronal cells, a dendrite or axon could be transfected deliberately without 
interfering directly with the soma.  The major disadvantage again is a high 
financial threshold and an additional level of training required to operate the 
device (Mehier-Humbert & Guy 2005). 
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Magnetofection has been considered a mechanical approach to transfection but is 
best used in conjunction with chemical reagents and viral vectors.  By 
precipitating DNA onto electrolyte coated, magnetic nanoparticles of iron oxide 
Christian et al. (2003) performed successful transfections on a range of eukaryotic 
cells using various transfection reagents and vectors.  They observed increased 
transfection by up to four orders of magnitude among the treatments.  Another 
improvement noted was that the time taken to achieve substantial transfection 
numbers was reduced from hours to mere minutes. 
Transfection and transformation have been used in conjunction with various other 
protocols to analyse the efficiency and result of the genetic fission.  An increasing 
number of researchers have turned to immuno-staining and integrated fluorescent 
proteins to label the organelles and proteins of interest.  By attaching an Hsp60 to 
a GFP label through genetic manipulation, a cell can be observed from the outside 
through fluorescence microscopy without needing to add invasive labelling 
chemicals during the time of testing.  In order to understand the affect florescence 
can have on a sample we need to understand first what the fluorescence 
phenomenon is.    
 
1.5 Fluorescence in Cell Culture Analysis 
1.5.1 Fluorescence in Problem Solving 
The use of fluorescent chemicals to analyse biological systems was pioneered 
around the 1980s.  The original fluorescent probes were at first too inefficient to 
produce consistent and reliable data.  Often the wavelength was too short and the 
extinction coefficient was poor.  These short comings often resulted in cellular 
autofluorescence and a fleeting signal.  More complicated problems involved 
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compromising cellular integrity to achieve a significant signal (Grynkiewicz et al. 
1985). Grynkiewicz et al. (1985) were the first to present data showcasing a, then, 
new generation of advantageous fluorescent probes.  These were stilbene 
chromophores attached to chelating molecules that targeted primarily Ca
2+
 in red 
blood cells. 
The benefits of fluorescent imaging and processing have encouraged the further 
development of the technology and it has expanded into many different 
applications.  Photo induced electron transfer (PET) is based on a system where a 
fluorophore becomes excited by electron donation from an adjacent receptor.  In 
practise, a sample is placed in the presence of a receptor which binds to target 
molecules and then excites the fluorophore to emit a conformation signal.  
Internal charge transfer (ICT) is similar to PET, except that the fluorophore is 
integrated firmly with the receptor and can demonstrate degrees of change.  
Fluorescence resonance energy transfer is used to detect the energy states of 
pairing molecules and the transmission of energy between them (Callan et al. 
2005). 
 
1.5.2 Fluorescence-Assisted Research 
Since studies began on the genome we have been able to characterise biological 
systems as well as define the codes of life.  Further studies produced the 
transcriptome which gave us insights into how DNA is used in cells.  Research on 
the proteome has shown us how the DNA is translated into cells while the newly 
described toponome will illuminate the interactions between all of these cellular 
components (Golzhauser et al. 2010, Schubert 2010).   
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Understanding the factors which make up the toponome have allowed researchers 
to understand the workings of healthy and compromised cells alike.  Wang et al. 
(2008) introduced a GFP tagged Hsp70 to bovine aortic endothelial cells.  They 
treated the cells on a heat perfusion stage by temporarily heating the cells to 42
o
C 
and continuously observed the expression of the Hsp70-GFP.  The natural Hsp70 
was stained with red fluorescence and the colocalisation of the red and green 
fluorescence was observed.  This approached gave the researchers evidence that 
the GFP tagged Hsp70 was incorporated correctly and that heat shock had caused 
a small amount of Hsp70 to migrate from the cytoplasm to the nucleus.  They 
postulated that Hsp70 may be involved in alleviating stress in the nucleus, in 
addition to its known cytoplasmic duties. 
The maturation of Golgi apparatus cisternae in yeast was eluded using a GFP and 
RFP attached to various Golgi structural proteins.  Secretory cargo proteins are 
usually moved through the Golgi and are processed with glycosylation and 
phosphorylation.  By viewing the fluctuations of the two fluorescent proteins 
inside the cisternae during post translation of cargo proteins, Losev et al. (2006) 
provided evidence that the cisternae mature as the cargo proteins move through 
the Golgi suggesting that the maturation is a result of post translational processing. 
A caveat must be heeded when using certain fluorescent approaches, especially 
when inserting genetic material designed to create a house keeping gene 
augmented with a fluorescent protein.  Wang et al. (2008) noted during treatments 
that the Hsp70-GFP used resulted in an Hsp70-GFP expression seven times lower 
than the natural Hsp70.  Earlier research has given evidence that adding a GFP to 
a fundamental protein can redirect the state of the host cell.  Aokage et al. (2004) 
found that adding a Bcl-2 family protein with a GFP caused mitochondria to 
aggregate at the cell membrane and initiate apoptosis.  
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1.6 Aims and Objectives 
Diabetes Mellitus has proven to be a complicated disease that has adversely 
changed the lives of millions of people around the world.  Looking at the 
biochemistry of diabetics has shown intriguing signs leading researchers to 
conclude that key proteins may be involved in the development and pathology of 
the disease.  Hsp60 typically has been implicated with intercellular signalling 
during inflammation and has elevated levels in diabetic circulation. 
In this study we will look to transform the E. coli strain, DH5α, with a vector 
containing the gene for human Hsp60 (HSPN1) which is at the 3’ end of a green 
fluorescent protein (GFP).  The vector will then be multiplied within the growing 
DH5α.  Methods for the vector DNA extraction will then be looked at and then an 
effective method employed to produce endotoxin-free DNA (endotoxin, also 
known as lipopolysaccharide, is produced by DH5α and can cause altered Hsp60 
expression in mammalian cells).  We will then investigate the transfection of the 
human cervical cancer cell line ‘HeLa’ with the extracted DNA.  The transfection 
efficiency will be investigated and an effective method of transfection determined. 
Lastly, we will use laser-scanning confocal microscopy to image live transfected 
HeLa cells.  Hsp60 has a role in the cellular stress response so the expression and 
location of the attached GFP signal will be imaged alongside fluorescently 
labelled mitochondria.  Transfected cultures will be put through treatments to test 
the movement of the Hsp60-GFP.  Sodium azide will be used to stress 
mitochondria which concomitantly can alter Hsp60 expression.   A high glucose 
concentration will also be used to stress the transfected cells as hyperglycaemia 
has been implicated in the translocation of circulating Hsp60 in diabetics.      
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Overall this study aims to investigate the colocalisation between the Hsp60-GFP 
and mitochondria.  We aim to determine if using the Hsp60-GFP and examining it 
through confocal microscopy can provide insight into the movement of Hsp60 out 





2.1 Media, Reagents and Common Solutions Prepared 
Name Composition 
LB Broth 10 g Tryptone 
5 g yeast extract 
10 g NaCl 
Dissolve in 800 ml RO H2O and adjust to pH 7 








0.5 g ampicillin 
Bring volume to 5 ml with RO H2O to make 292 mM 
ampicillin 
Filter sterilise through a 0.2 µm filter 
Take 500 µl of 292 mM ampicillin 
Add with LB broth to make 500 ml 
Store at 4
o
C, use within 3 days 
 
LB agar 5 g tryptone 
2.5 g yeast extract 
5 g NaCl 
Dissolve in 450 ml RO H2O and adjust to pH 7.5 
Add 7.5 g agar and heat in microwave to nearly boiling 








0.5 g ampicillin 
Bring volume to 5 ml with RO H2O to make 292 mM 
ampicillin 
Filter sterilise through a 0.2 µm filter 
Take 500 µl of 292 mM ampicillin 
Add with 60
o
C autoclaved LB agar to make 500 ml 





TE pH 8.0 10 ml 100 mM Tris-HCl pH 8.0 
10 ml 10 mM EDTA pH 8.0 
80 ml RO H2O 
 
0.2 M NaOH + 1% 
SDS 
0.8 g NaOH 
Dissolve in 50 ml RO H2O 
1g SDS 
Bring volume to 100 ml with RO H2O 
 
3 M K acetate pH 
5.2 
29.44 g K acetate 
70 ml RO H2O and adjust to pH 5.2 
Bring volume to 100 ml with RO H2O 
 
0.1 M CaCl2 + 1% 
PEG8000 
1.10 g CaCl2 
1 g PEG8000 








8 g NaCl 
0.2 g KCl 
1.44 g Na2HPO4 
0.24 g KH2PO4 
Dissolve in 800 ml RO H2O and adjust to pH 7.4 
Bring volume to 1 L 
 
HeLa DMEM media 0.011 g pyruvic acid 
0.45 g glucose 
2.5 ml 4.5 mM NaHCO3 
2 ml 5000X penicillin/streptomycin 
1 ml 100X amino acid solution 
Bring volume to 100 ml with 1X DMEM 
Remove 10 ml and replace with 10 ml FBS 





HeLa DMEM media 
100 mM glucose 
0.135 g glucose 
Make up to 10 ml with HeLa DMEM media 











HeLa DMEM media 
25 µM sodium azide 
0.065 g sodium azide 
1 ml HeLa DMEM media, mix to make 1 M sodium 
azide 
Take 10 µl 1 M sodium azide 
Add with 990 µl HeLa DMEM media 10 mM sodium 
azide 
Take 100 µl 10 mM sodium azide 
Add with 900 µl to make 1 mM 
Take 1 ml of 1 mM sodium azide 
Add with 9 ml HeLa DMEM media to make 100 µM 




Dilute aliquot by 4X to make 25 µM sodium azide 
before use 
 
4.5 mM NaHCO3 1.5 g NaHCO3 





0.5 M EDTA 14.61 g EDTA 
Dissolve in 80 ml RO H2O and adjust to pH 8.0 
Bring volume to 100 ml 
 
10 mM EDTA pH 
8.0 
0.292 g EDTA 
Dissolve in 80 ml RO H2O and adjust to pH 8.0 
Bring volume to 100 ml 
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100 mM Tris-HCl 
pH 8.0 
0.121 g Tris 
Dissolve in 80 ml RO H2O and adjust to pH 8.0 




54 g Tris base 
27.5 g boric acid 
20 ml 0.5 M EDTA pH 8.0 




200 ml 5X TBE 
Bring volume to 1 L with RO H2O  
 
1% agarose gel in 
1X TBE 
1 g agarose 
Bring volume to 100 ml with 1X TBE 
Heat in microwave on high for 1 min 30 sec 
Stir contents 
Heat in microwave on high for another 1 min 30 sec 
Bring volume to 100 ml with 1X TBE 
Add 2.5 µl 25 mM ethidium bromide 
Pour into gel tray at 50
o








1 µM Mitotracker 
CMX Ros (CMX 
Ros) stock solution 
50 µg CMX Ros 
Dissolve in 94 µl DMSO to make 1 mM CMX Ros 
Take 10 µl of 1 mM CMX Ros 
Add with 9.99 ml to make 10 ml 1 µM CMX Ros 




50 nM Mitotracker 
CMX Ros (CMX 
Ros) working 
solution 
500 µl 1 µM CMX Ros 
Add with 500 µl HeLa DMEM media to make 500 nM 
CMX Ros 
Take 100 µl of 500 nM CMX Ros 
Add with 900 µl HeLa DMEM media to make 50 nM 
CMX Ros 





2 µl 1.5 mM PI 







2.2 Statistical Analysis 
All statistical analyses in this project were calculated using Microsoft Excel.  The 
mean values for the data were processed as necessary and the standard error of the 




Equation 2.1 – The equation used to calculate the standard error of the mean in 
Microsoft Excel. 
 
Single-tailed and two-tailed student’s t-tests were used to compare and determine 
significance between data sets.  The accepted level of significance was p < 0.05.  






3 Transformation and Purification of RG224428 from 
E. coli DH5α Cells 
3.1 Introduction 
The RG224428 plasmid used in this study was purchased from Origene in a 10 µg 
aliquot.  It contains a Homo sapiens HSPD1 gene at the 3’ end of a green 
fluorescent protein (GFP) gene (Figure 3.1).  These genes are located at the 5’ 
end of a eukaryotic CMV promoter which is crucial to their transcription within 
eukaryotic cells.  The GFP protein has a 26 kDa, 232 amino acid structure and is 
referred to in the literature as TurboGFP (Evdokimov et al. 2006).  The GFP 
protein originated from Pontellina plumata (a Copepoda species) as the ppluGFP2 
protein.  The TurboGFP is an optimised version of its derivative and is designed 
to avoid aggregation within the cytosol.  Upon correct folding the GFP has an 
excitation maximum at 482 nm and an emission maximum at 502 nm (Evdokimov 
et al. 2006). 
Another important gene incorporated into the plasmid is Amp, an ampicillin 
resistance gene.  This gene will be used to select out transformed bacterial cells 
growing in competitive media (laced with ampicillin).  Upon transcription the 
mRNA is translated to form a human Hsp60 protein with a GFP protein connected 
to the C-terminus.  The sequencing for this plasmid was performed previously 
(personal communication, Martinus).  In order to produce the necessary quantity 
and quality of RG224428 plasmid required for our study transformation and 
extraction protocols were employed to assess their effectiveness on DH5α E. coli.  
This section describes the successful protocols used to produce viable RG224428 
plasmid.  The transformation and extraction experiments were analysed on petri 
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dishes and agarose gels respectively.  A NanoDrop was further employed to test 
the quantity and quality of the extracted DNA.   
 
 
Figure 3.1 – Gene map for RG224428.  The HSPD1 gene encodes for the human Hsp60 








3.2 Methods  
3.2.1 Growing DH5α E. coli Cells 
The E. coli strain DH5α was purchased from Invitrogen.  The advantage of using 
DH5α cells are they yield a high copy number of the cloned plasmid after 
transformation.  The cells were grown in LB broth at 37
o
C in an incubator.  A 
colony was taken from a previously streaked LB agar plate and placed in 100 ml 
LB broth, mixed periodically and grown overnight.  The following day 100 µl of 
inoculated LB broth was streaked onto newly prepared LB agar plates.  The 
inoculated plates were stored at 4
o
C.  When a culture was required for research, 1 
to 2 colonies would be removed from the plates and grown overnight in LB broth 
at 37
o
C.  An aliquot for research would be taken from the resultant growth. 
 
3.2.2 Generation of Chemically Competent DH5α E. coli Cells 
DH5α was grown overnight on an LB agar plate at 37oC.  A resulting colony was 
added to 10 ml LB broth and placed in a shaking incubator at 37
o
C for 3 hr 30 min 
at 10 rpm.  A 1.5 ml aliquot of culture was then centrifuged at 14,000 rpm for 2 
min to pellet the cells.  All supernatant was discarded and the pellets were 
resuspended in 100 µl of 0.1 M CaCl2 containing 1% PEG8000 to make the cells 
competent (ready to take up external DNA from the environment).  CaCl2 was 
used in order to improve the permeability of the cell membranes and therefore 
improve the uptake of the introduced plasmid (Aich et al. 2012).  Polyethylene 
glycol 8000 (PEG8000) also improves the permeability of cell membranes by 
forming pores and by adding it to a cell permeabilising media (CaCl2) can 
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increase the transfection efficiency by 100-300 fold (Tu et al. 2005; Tostado et al. 
2012).   
 
3.2.3 Transformation of PUC19/Hsp60-GFP into DH5α E. coli 
Competent cells were incubated on ice for 5 min were upon an aliquot of plasmid 
suspended in TE (pH 8.0) was added.  PUC19 had a concentration of 29.4 ng/µl 
and RG224428 had a concentration of 434.3 ng/µl (see 3.2.4).  No plasmid was 
added to the control samples and their volume was brought up to match the 
volume of the treated samples with TE (pH 8.0).  The tubes were mixed by 
inversion and the sample was further incubated on ice for 20 min with periodic 
gentle mixing (every 5 min).  Immediately after the 20 min incubation the sample 
was placed into a thermomixer at 42
o
C for 45 sec at 900 rpm.  The sample was 
removed and 900 µl of pre-warmed (37
o
C) LB broth was added and the sample 
placed again into a shaking incubator at 37
o
C for 1 hr.  The sample was 
centrifuged at 14,000 rpm for 2 min to pellet the cells and the supernatant was 
discarded.  The cells were then resuspended in 100 µl of pre-warmed (37
o
C) LB 
broth and aliquots of 30 µl were pipetted on to LB agar plates and spread with a 
sterile spreader.  Treated samples were aliquoted onto two LB agar plates and four 
LB ampicillin agar plates.  Control samples were added to LB agar and LB 
ampicillin agar plates.  The inoculated plates were incubated overnight at 37
o
C.  
Once the growth became substantial the plates were then stored at 4
o
C.  When a 
culture was required for research, 1 to 2 colonies would be removed from the 
plates and grown overnight in their respective LB broth systems (eg. with 
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ampicillin if taken from an ampicillin plate) at 37
o
C.  An aliquot for research 
would be taken from the resultant growth.   
 
3.2.4 Quantification of DNA 
DNA was quantified using a NanoDrop 2000 spectrophotometer (NanoDrop).  
Using the NanoDrop relies on the principle that DNA absorbs light at peak 260 
nm.  This absorption is due to interaction between 260 nm light and the aromatic 
nature of the pyrimidine (thymine and cytosine) and purine (guanine and adenine) 
bases (Markovitsi et al. 2010).  The amount of light that is absorbed is subtracted 
from the light that is emitted to generate an absorbance curve.  The quality of the 
DNA can also be assessed since many other by-products of DNA extraction peak 
at different wavelengths (ie. phenol peaks at 270 nm).  By calculating the 260/280 
and 260/230 ratio the purity can also be assessed as other non-DNA products 
(such as protein which peaks a 280 nm) peak within these regions.  A 260/280 
ratio between 1.8 and 2 and a 260/230 ratio higher than 1.5 indicate highly pure 
DNA. 
The concentration of extracted PUC19 was calculated as 142.4 ng/µl with a 
260/280 ratio of 2.03.  The 260/230 ratio was 2.17.  The concentration of 
extracted RG224428 was calculated as 30.7 ng/µl with a 260/280 ratio of 1.87 and 






3.2.5 Restriction Digestion of DNA 
A single digest was performed adding 2 µl restriction enzyme buffer (Roche), 7 µl 
MQ water, 1 µl EcoR1 or NdeI restriction enzymes (Roche) and 10 µl DNA.  NdeI 
contains a restriction site CATATG found on PUC19.  EcoR1 cuts at the 
restriction site GAATTC, which is contained on RG224428.  By using a single 
digest the DNA is cleaved in to single bands that can run through agarose gel and 
be compared with a DNA ladder (graded with single band DNA). Samples were 
incubated in a thermomixer at 37
o
C for 1 hr at 900 rpm.  The digested samples 
were immediately prepared for analyses on agarose gel.   
 
3.2.6 Detecting DNA on Agarose Gel Electrophoresis 
To assess the size of the extracted DNA aliquots the samples were analysed by 
agarose gel alongside samples of either pure PUC19 or RG224428, respectively.  
A 100 bp ladder (Dnature) was used to assess the size of PUC19 fragments.  The 
ladders maximum size was 3000 bp which was adequate for the 2,686 bp PUC19.   
A 1,000 bp ladder (Dnature) was used to gauge the size of the RG224428 DNA.  
The ladders maximum size was 10,000 bp, adequate for the 8,300 bp RG224428.  
Digested samples and undigested samples (20 µl each) were mixed with 5 µl 
loading dye, 20 µl of which were pipetted into the wells of 1% agarose gel in 1X 
TBE.  Upon initial agarose gel analyses the pure RG224428 proved to be too high 
a concentration for efficient gel analyses.  The DNA needed to be diluted to 
achieve better parity with the extracted DNA samples and ladder.  The pure 
RG224428 (suspended in TE pH 8.0; 868.6 ng/µl) 1 µl was diluted with 27 µl of 
TE pH 8.0 to bring the concentration down to a similar level as the extracted DNA 
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(diluted pure RG224428 was approximately 31.02 ng/µl while the extracted DNA 
in similar TE was 30.7 ng/µl).   
 
3.2.7 Purification of DNA 
3.2.7.1 Purification of PUC19 DNA 
One colony of DH5α+PUC19 was taken from LB ampicillin agar plates and used 
to inoculate 200 ml LB ampicillin.  The culture was incubated overnight at 37
o
C.  
A 1.5 ml sample of the culture was pipetted in a tube and centrifuged for 13,000 
rpm for 1 min.  The supernatant was discarded and pellet resuspended in 200 µl 
ice cold GTE.  Fresh 0.2 M NaOH containing 1% SDS buffer (300 µl) was added 
and the sample mixed gently by inversion.  Next, 300 µl of 3 M K acetate pH 5.2 
was added and the sample was again gently mixed by inversion for 30 sec.  The 
tube was incubated on ice for 10 min and then centrifuged at 13,000 rpm for 10 
min.  The resulting supernatant was transferred to a new sterile, unused tube.  
RNase (2 µl; 2 mg/ml) was added and the sample incubated at 37
o
C for 10 min in 
a thermomixer at 900 rpm.  Chloroform (600 µl) was then added and the tube 
mixed by inversion for 30 sec.  The tube was then centrifuged at 13,000 rpm for 1 
min and a 500 µl aliquot of aqueous supernatant was transferred into another new 
sterile, unused tube.  Chloroform (600 µl) was added to this latest sample and 
mixed by inversion for 30 sec where upon it was centrifuged at 13,000 for 1 min.  
The aqueous supernatant (400 µl) was then transferred to a new sterile, unused 
tube along with 600 µl of absolute isopropanol.  The sample was centrifuged at 
13,000 for 10 min to precipitate the DNA.  The supernatant was carefully 
removed and the pellet was washed in 500 µl of 80% ethanol by centrifugation at 
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13,000 rpm for 1 min after which the ethanol was removed and the pellet left to 
air dry for 5 min.  This final pellet was resuspended in 25 µl TE pH 8.0 and left to 
dissolve for 30 min. 
The DNA was quantified using a NanoDrop 2000 spectrophotometer (NanoDrop) 
as discussed in 3.2.4.  The concentration was calculated as 142.4 ng/µl with a 
260/280 ratio of 2.03.  The 260/230 ratio was 2.17.   
 
3.2.7.2 Purification of RG224428 DNA 
In order to purify RG224428 cloned in DH5α cells a plasmid extraction was 
performed using a QIAGEN EndoFree Plasmid Maxi Kit (QIAGEN Cat. no. 
12362) and performed closely to the manufacturer’s protocol with slight 
alterations.  By using the kit we could ensure that the plasmid was extracted and 
purified to produce endotoxin free DNA.  The need for endotoxin free DNA is 
due to the later transfection of eukaryotic HeLa cells (4.2.2).  Endotoxin (also 
called lipopolysaccaride (LPS)) is produced by bacteria and usually resides in 
their cell walls.  LPS has the ability the ligand with the TLR4 receptor found on 
eukaryotic cells including HeLa.  Activation of the TLR4 receptor results in an 
immune response leading to inflammation (Raetz & Whitfield 2002).  In order to 
use RG224428 cloned in DH5α bacteria for mammalian transfection the LPS 
needs to be removed to avoid false reading in our treatments.  LPS exposure to 
mammalian cells causes upregulation and translocation of Hsp60 (Davies et al. 
2006; Li et al. 2009). 
LB ampicillin broth (100 µl) was inoculated with a transfected cell colony and 
incubated overnight at 37
o
C.  The entire 100 µl culture was then split into 25 µl 
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aliquots, each placed into a 50 ml tube.  The tubes were centrifuged in a 
refrigerated (4
o
C) centrifuge at 6,000 g for 15 min.  The supernatant was 
discarded and the pellets were systematically resuspended in 10 ml buffer P1, 
collecting each pellet until all the cells and the 10 ml buffer were contained in one 
tube.  Next, 10 ml of buffer P2 was added and the tube was mixed by inversion 
and incubated at RT for 5 min.  Immediately 10 ml of pre-chilled (in fridge, 4
o
C) 
buffer P3 was added mixed by inversion.  The resulting lysate was poured into a 
QIAfilter cartridge (cap on) and incubated at RT for 10 min.  The lysate was 
filtered through the cartridge using the plunger into a sterile, unused 50 ml tube.  
Buffer ER (2.5 ml) was added to the filtrate and then the contents were mixed by 
inversion and incubated on ice for 30 min.  Buffer QBT (10 ml) was added to an 
endotoxin free QIAGEN-tip 500 to calibrate the filter and was emptied by gravity 
flow.  The filtered lysate was then added to the QIAGEN-tip 500 and allowed to 
empty via gravity flow into a separate 50 ml tube.  The QIAGEN-tip 500 was 
further washed using two aliquots of buffer QC (30 ml) and emptied by gravity 
flow.  To elute the DNA 15 ml buffer QN was added to the filter tube and a new 
sterile, unused 50 ml tube was placed in order to catch the DNA filtrate.  At this 
point the DNA extraction sample was stored overnight in a fridge at 4
o
C.  The 
following day 10.5 ml of isopropanol was added to the DNA sample and mixed 
by inversion.  Immediately the sample was centrifuged in a refrigerated (4
o
C) 
centrifuged at 5,000 g for 1 hr.  The supernatant was decanted and 5 ml endotoxin 
free 70% ethanol was added and the sample centrifuged again at 5,000 g for 1 hr 
(4
o
C).  The ethanol was decanted and the pelleted left to air-dry for 30 min.  
Endotoxin free buffer TE (2 ml) was added and the pellet gently resuspended by 
stirring and inversion.  The sample was left undisturbed to dissolve in the buffer 





The DNA was quantified using a NanoDrop 2000 spectrophotometer (NanoDrop) 
as discussed in 3.2.4.  The concentration was calculated as 30.7 ng/µl with a 






3.3.1 Transformation of DH5α E. coli  
Various chemical methods were used to transform DH5α cells but one method 
alone proved effective for our study.  In order to ensure success before using the 
RG224428 plasmid (contains human Hsp60 with a GFP at the C-terminus) 
(Figure 3.1), PUC19 was used as the treatment plasmid.  The ineffective methods 
were all chemical based and relied on incubating the treated cells on ice and at 
approximately 37
o
C.  All of these resulted in an absence of growth on competitive 
media.  The first ineffective method used super optimal broth containing super 
optimal broth with catabolite repression (SOC) media accompanied by 2M MgCl2 
(cell permeabilisation) and 1M glucose and after incubation on ice was incubated 
at 37
o
C for 45 min.  The second ineffective method used transformation & storage 
solution (TSS)(Iiiumina), PEG 6000, dimethyl sulphoxide (DMSO) and MgSO4.  
After incubation on ice the treated cells were placed in a 42
o
C waterbath and 
incubated at 37
o
C for 45 min. 
The successful method (shown in 3.2.3) which yielded generous numbers of 
colonies growing on competitive media used 0.1M CaCl2 and PEG 8000.  After 
incubation on ice the treated cells were placed into a thermomixer at 42
o
C and and 
incubated at 37
 o
C for 60 min.  Figure 3.2 and Figure 3.3 shows the different 
growth rates between the control samples and the treated samples.  Figure 3.2a 
shows non-treated control DH5α grown to confluence, on standard LB agar.  
Figure 3.2b yielded no growth of non-treated DH5α on LB ampicillin competitive 
media.  Figure 3.2c shows generous but non-confluent growth for DH5α 
transformed with the PUC19 growing on the same LB ampicillin.  Since PUC19 
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contains a gene for ampicillin resistance it was deduced that the transformation 
was successful. 
Due to the successful results of this protocol it was employed for use with 
RG22428.  RG224428 also contains a gene for ampicillin resistance and the 
pictures in Figure 3.3a-c shows similar results to that seen with PUC19.  
 
 
Figure 3.2 –  DH5α E. coli PUC19 transformation plates.  a)  Confluent DH5α grown on 
LB agar plate.  b) DH5α grown on LB ampicillin agar plate.  c) DH5α transformed with 
PUC19 (contains ampicillin resistance gene) grown on LB ampicillin agar.  
 
 
Figure 3.3 – DH5α E. coli RG224428 transformation plates.  a) DH5α grown on LB agar 
plate.  b) DH5α grown on LB ampicillin agar plate.  c) DH5α transformed with 










3.3.2 Plasmid Extraction from DH5α E. coli Cells 
The initial method used to extract the PUC19 plasmid from transformed DH5α 
incorporated TENS pH 8.0 and 3M NaOAc pH 5.2 into the protocol.  The 
resultant supernatant was washed in a 1:1 phenol/chloroform solution.  When 
analysed under a NanoDrop, the data revealed potential contamination of the 
isolated DNA with phenol as indicated by a second peak at approximately 270 nm 
(the peak absorption of phenol; pure DNA peak absorption is 260 nm).   
Phenol/chloroform is used in the protocol to help precipitate the DNA from the 
supernatant.  An aqueous phase is developed which contains the DNA with the 
phenol/chloroform in the lower supernatant.  Figures 3.4-3.6 show our attempts to 
wash the phenol from the DNA.  The different lines indicate the differing 
quantities of DNA that resulted from various different washing steps.  The 
extraction samples at this stage contain DNA, phenol, chloroform and isopropanol 









Figure 3.4 – Graph of PUC19 DNA samples extracted using phenol on a NanoDrop 
spectrophotometer.  The lines show UV light absorption on PUC19 extraction samples 
extracted.  Samples were centrifuged at the phenol/chloroform step for various times.  a) 
Sample was centrifuged for 10 min.  b) Sample was centrifuged for 20 min (10 min 
twice).  c) Sample was centrifuged for 30 min (10 min thrice). 
Figure 3.4a, b and c were centrifuged for 10 min, 20 min and 30 min, respectively 
(b and c were performed in consecutive 10 min rounds).  The concentrations 
declined with increased centrifugation time.  The concentrations were 19.63 ng/µl, 
16.49 ng/µl and 11.56 ng/µl for a, b and c, respectively.  Figure 3.5a, b and c 
show data from the same protocol using the same centrifugation times (10, 20 and 
30 min, respectively) but the samples were refrigerated overnight (4
o
C).  The 
concentrations were more similar to each other with figures of 24.48 ng/µl, 20.69 
ng/µl and 20.50 ng/µl for a, b and c, respectively.  Figure 3.6 is produced from a 
slightly different protocol.  The phenol/chloroform centrifugation step was set to 
10 min but the aqueous DNA was washed in progressively more chloroform (with 
intentions to remove the phenol).  As more chloroform steps (200 µl chloroform 
each) are employed there is a decline in phenol but also a decline in DNA.  
Figure 3.6a, b, c and d show this decline (a had 1 wash; b 2 washes; c 3 washes; d 
4 washes).  The concentration of DNA was calculated as 111.24 ng/µl, 42.20 






show the same 270 nm peak indicative of phenol contamination.  As more phenol 
was removed, DNA was lost. 
 
Figure 3.5 – Graph of PUC19 DNA samples extracted and incubated overnight using 
phenol on a NanoDrop spectrophotometer.  The lines show UV light absorption on 
PUC19 extraction samples.  Samples incubated at 4
o
C overnight and then centrifuged at 
the phenol/chloroform step for various times.  a) Sample was centrifuged for 10 min.  b) 
Sample was centrifuged for 20 min (10 min twice).  c) Sample was centrifuged for 30 min 
(10 min thrice).  The lines for b) and c) overlap. 
 
 
Figure 3.6 – Graph of PUC19 DNA samples extracted using phenol and washed various 
times with chloroform on a NanoDrop spectrophotometer.  The lines show UV light 
absorption on PUC19 extraction samples.  Each DNA sample washed in 200 µl 
chloroform a different amount of times.  a) Sample was washed once.  b) Sample was 
washed twice).  c) Sample was washed three times).  d) Sample was washed four times.  
The lines for c) and d) overlap. 
 
Due to the difficulty of phenol removal we moved to a new protocol that 










5.2.  No phenol was used in the protocol.  The NanoDrop results showed a pure 
sample with a 260/280 ratio of 2.04 and a 260/230 ratio of 2.38 as shown in 
Figure 3.7.  The concentrations recorded were 142.4 ng/μl and 149.9 ng/μl.  The 
extracted PUC19 DNA was analysed on agarose gel electrophoresis alongside 
pure PUC19 DNA. 
 
Figure 3.7 – Graph of relatively pure PUC19 DNA extraction samples analysed on a 
NanoDrop.  The lines show a considerably pure plasmid DNA sample with singular peaks 
at 260 nm.  The highest peak shows a concentration of 149.9 ng/μl.  The lower peak is 
142.4 ng/μl. 
 
The pure uncut DNA in Figure 3.8 lane 3 reveals multiple banding.  This is 
indicative of the different forms that pure DNA plasmid can be found in 
(multimeric, circular, linear and supercoiled).  Supercoiled DNA can be seen as 
the lowest band as it is more compact and has run further through the gel than 
linear strands.  Circular DNA can be seen above with the multimeric strands 
(DNA strands bound together) at the top.  The single-digested pure DNA can be 
seen in lane 4.  It is linear and has lined up with the ladder DNA (also linear) to 
show a band between 2,000 bp and 3,000 bp (PUC19 is 2,686 bp).  Lane 5 and 7 
shows uncut extracted DNA (circular) while lane 6 and 8 reveal faint bands that 
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line up with the pure cut PUC19 DNA.  Double banding occurred on the gel and it 
is thought this was due to a shorter-than-usual incubation time between the DNA 
and ethidium bromide.  Carlsson et al. (1995) reported this occurrence with tests 
they performed.  They found that short incubation times with bis-intercalating 
dyes (including ethidium bromide) could cause multiple banding.  They 
postulated that it was due to uneven staining of DNA strands.  Strands with more 
dye would run slower while bands with less dye would run ahead causing either a 
second band or a smear.  The DNA quantities were calculated to be > 14.7 ng/μl 
in extraction samples that were put through a single digest with NdeI (Figure 3.8).  
Despite the comparatively low DNA yield seen on the gel (spectral analyses 
showed up to 149.9 ng/μl) this protocol was considered a worthy alternative to the 






Figure 3.8 – Agarose gel electrophoresis of PUC19 extracted from DH5α.   Double 
banding is evident due to a shorter than usual incubation time for the DNA and ethidium 
bromide.  The pure plasmid was 25 ng/μl.  The spectral analysis calculated the extracted 
plasmid as 149.9 ng/μl.  Lane 1: 5 µl 100 bp DNA ladder (100-3000 bp).  Lane 2: empty.  
Lane 3:  20 µl pure PUC19 uncut.  Lane 4: 20 µl pure PUC19 cut.  Lane 5: 20 µl 
extracted PUC19 uncut.  Lane 6 20 µl extracted PUC19 cut.  Lane 7: 20 µl extracted 
PUC19 uncut.  Lane 8: 20 µl PUC19 cut.  
 
The use of the QIAGEN plasmid maxi kit proved successful.  A NanoDrop 
analysis confirmed the extraction sample had a good level of purity with a 
260/280 ratio of 1.87 and a 260/230 ratio of 3.13 as seen in Figure 3.9.  The 
concentration was calculated as 30.7 ng/μl.  Figure 3.10 shows an image of 
extracted RG224428 analysed using agarose gel electrophoresis.  Lane 2 shows 
the multiple banding of pure uncut RG224428.  Lane 4 shows single-digested 
pure RG224428 at approximately 8,000 bp (RG224428 is 8,300 bp).  Lane 5 
shows the multiple banding of extracted RG224428.  Lane 7 shows a band of 
extracted RG224428 which is in line with the pure cut sample.   
 
 




























Figure 3.9 – Graph of RG224428 DNA extraction samples using QIAGEN plasmid maxi 
kit analysed on a NanoDrop.  The lines show a considerably pure plasmid DNA sample 


















Figure 3.10 – Agarose gel electrophoresis of RG224428 extracted from DH5α.  The pure 
DNA was diluted to a concentration of 30.7 ng/μl to match the extracted DNA (30.7 
ng/μl).  Lane 1: 5 µl 1,000 bp DNA ladder (1,000-10,000 bp).  Lane 2: 5 µl pure 
RG224428 uncut.  Lane 3: 5 µl pure RG224428 cut with Hind III (obsolete).  Lane 4: 5 µl 
pure RG224428 cut with EcoR1.  Lane 5: 5 µl extracted RG224428 uncut.  Lane 6: 5 µl 
extracted RG224428 cut with Hind III (obsolete).  Lane 7: 5 µl extracted RG224428 cut 
with EcoR1.  Lane 8: 2.5 µl pure RG224428 cut with Hind III (obsolete).  Lane 9: 2.5 µl 
pure RG224428 cut with EcoR1.  Lane 10: 2.5 µl extracted RG224428 cut with Hind III 
(obsolete).  Lane 11: 2.5 µl extracted RG224428 cut with EcoR1. L.  Lane 12: 5 µl 1,000 
bp DNA ladder (1,000-10,000 bp). 
 
  


























3.4 Discussion  
The objective of this study was to clone and purify RG224428 plasmid DNA into 
a state suitable for mammalian cell transfection.  As the initial quantity of 
RG224428 was low (10 µg) the PUC19 plasmid was used to optimise 
transformation and purification procedures.  The gram-negative bacteria DH5α E. 
coli (DH5α) was used for the transformation and cloning of both of the plasmid 
vectors.  The method used to perform the transformation incorporated CaCl2, a 
known cell permeabilising agent (Aich et al. 2012), with polyethylene glycol 
8000 (PEG8000).  PEG8000 can create pores in cell membranes and it is thought 
that the combination of CaCl2 and PEG8000 improve the chances of DNA uptake 
(Tu et al. 2005; Tostado et al. 2012).  Transformed DH5α cells were then grown 
and plasmid DNA extractions were performed.  The concentration and quality of 
the extracted DNA was assessed using a NanoDrop 2000 spectrophotometer 
(NanoDrop).  The extracted plasmids were then processed with restriction 
enzymes (single-digest) to produced single bands of DNA which were measured 
on agarose gel electrophoresis.  
The Escherichia coli strain DH5α has been successfully used many times in 
research to clone plasmid vectors containing genes of interest.  Contemporary 
studies have used DH5α’s ‘high-copy number plasmid’ properties to clone genes 
for industrial applications.  Ariff et al. (2009) used DH5α to clone the gene for the 
xylanase enzyme, an enzyme unnatural to E. coli strains.  Xylanase is used to 
break down hemicellulose in plants (an increasingly important reaction for fuel 
production).  Karthikeyan et al. (2011) transformed DH5α with a vector 
containing the gene for penicillin G acylase (naturally found in B. Badius pac).  
Penicillin G acylase is an important enzyme in producing 6-amino penicillanic 
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acid (6-APA), a key molecule used to produce semi-synthetic penicillins.  DH5α 
has been used to produce fluorescent indicator proteins in the past.  DH5α was 
transfected with arsenate resistance (arsR) gene regulators attached to a GFP.  The 
model was used to design a system where E. coli can be used to detect arsenic (a 
toxin) in the environment.  In the presence of arsenic the DH5α would fluoresce 
under UV light (Tani et al. 2009).  In our study DH5α was effectively transformed 
with the plasmids PUC19 and RG224428 (seen in Figures 3.2-3.3, respectively).  
The PUC19 plasmid was used to optimise transformation and extraction protocols 
before using RG224428.  The RG224428 plasmid was used because it contains 
genes for a human Hsp60 with a GFP protein attached at the C-terminus.  The 
cloned plasmid would then be used to transfect human HeLa cells to detect 
Hsp60-GFP movement under stress (chapter 4).  
The extraction of plasmid DNA was initially performed on DH5α transformed 
with PUC19.  One of the protocols used first employed phenol.  Phenol is used in 
plasmid extractions because it has a lower polarity than water.  This molecular 
property means that it can repulse DNA into the adjacent water (the aqueous 
phase) during centrifugation (Morales & Zhan 2010).  Phenol also binds with 
proteins causing them to separate out of the aqueous phase.  It is in this aqueous 
phase that pure plasmid DNA should reside (Wang & Rossman 1994).  In our 
study, spectral analyses revealed that the phenol used to separate the plasmid 
DNA from cellular proteins was contaminating the purified DNA.  Different 
methods were used to rid the DNA of the phenol.  Longer centrifugation periods 
(centrifugation of samples containing phenol/chloroform and DNA) and extra 
washes with chloroform did not remove the phenol contamination but instead 
decreased DNA yields.  The contamination may have been caused by phenol 
binding to protein trapped in the aqueous phase.  Proteins, such as the 16 kDa 
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C1D (a pro-apoptotic protein) and the serpin proteins (Spi-1, Spi-2 and Spi-3; 
involved in DNA repair), have been known to bind tightly with DNA after 
deproteinisation (Sjakste et al. 2010).  If protein had been bound tightly to our 
DNA, or had a net polar charge, this may have contributed to the phenol 
contamination (as phenol also binds to proteins).  Despite the possibility of tightly 
binding protein being linked to the phenol contamination no other contaminants 
were detected or were as obvious as phenol in our spectral analyses.  Future 
extractions using phenol may need to incorporate a filter system to further remove 
particles that may contribute to phenol contamination.  Due to the difficulty in 
removing phenol we employed a different DNA extraction protocol which 
provided uncontaminated purified DNA. 
In order to purify the RG224428 plasmid for use in mammalian cells we used the 
QIAGEN Endo Free Plasmid Maxi Kit (QIAGEN).  The advantage of using this 
kit is that it incorporates filters that could effectively remove endotoxin, naturally 
a part of the DH5α cells.  Endotoxin-free solutions were also supplied.  
Endotoxin-free methods were required because the RG224428 plasmid DNA was 
to be used later to transfect mammalian HeLa cells (4.2.2).  Endotoxin (also called 
lipopolysaccharide (LPS)) is produced by bacteria (including DH5α) and usually 
resides in their cell walls.  LPS has the ability to ligand with the TLR4 receptor 
found on mammalian cells including HeLa.  Activation of the TLR4 receptor 
results in an immune response leading to inflammation (Raetz & Whitfield 2002).  
LPS has been shown to induce an immune response in HeLa cells.  Mineshiba et 
al. (2005) added LPS with HeLa cells to induce the synthesis of human beta-
defensin-2.  Millan-Mendoza et al. (2007) showed that LPS derived from 
Chlamydia trachomatis could cause apoptosis in HeLa cells.  Our research was 
designed to investigate the movement of the Hsp60-GFP encoded by RG224428.  
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The cells were to be induced by controlled cellular stressors which control could 
not be achieved if the HeLa cells were already contaminated with LPS (detailed in 
4.2.5).  LPS would not only affect the viability of the HeLa cells but could 
generate false-positive results for Hsp60 translocation.  Davies et al. (2006) 
demonstrated that LPS introduced into peripheral blood mononuclear cultures 
causes the release of Hsp60 into the extracellular space.  Li et al. (2009) also 
demonstrated that LPS administered to pancreatic tissue from mice causes 
significant increases in Hsp60 expression.  By avoiding contamination of 





4 Transfection of Hsp60-GFP into HeLa Cells and 
Colocalisation Analysis 
4.1 Introduction 
The human Hsp60 protein has many vital roles in human biology.  In order to 
induce the transcription and subsequent translation of the Hsp60-GFP contained 
on RG224428 a human cell line HeLa (or HeLa) cells, was purchased from the 
American Tissue Culture Collection (ATCC number: CCL-2).  The important 
component of this cell type is that RG224428 only contains a eukaryotic CMV 
promoter for the Hsp60-GFP gene (HSPD1-GFP)(Figure 3.1), which is naturally 
contained in virtually all eukaryotic cells including HeLa.  HeLa cells are also a 
feasible option for this developmental study. 
In order to perform a successful and adequate transfection of HeLa cells with 
RG224428 a chemical approach was used in the form of lipofectamine 2000 
(Invitrogen).  Lipofectamine 2000 reagent was purchased as a working solution of 
1 mg/ml.  Lipofectamine is a cationic lipid based transfection agent that forms 
liposomes in the transfection media (media design specifically for transfection).  
The positively charged (cationic) liposomes bind to negatively charged (anionic) 
DNA.  This creates a colloid of lipofectamine and DNA (lipofectamine/DNA 
complex).  The lipofectamine provides the ability to overcome the electrostatic 
repulsion that would usually inhibit naked DNA uptake.  The lipid properties also 
allow the lipofectamine to bind and pass through cell membranes (Dalby et al. 




Opti-MEM (Gibco, Life Technologies) is a reduced-serum media used during the 
transfection process to optimise transfection yields.  Protein content in normal 
growth media (in the presence of oxygen) can block the liposomal activity 
necessary for transfection (Fordada et al. 1997).  By using a reduced-serum media 
the effects of protein:liposome interaction are negated (Cheung et al. 2001). 
Laser scanning confocal microscopy has proven useful at examining biological 
systems in great detail.  The advantage of a confocal microscope is due to the 
confocal component which reduces the amount of scattered light passing through 
the lens.  This also helps process very thin images (in the Z-dimension) which are 
useful for colocalisation.  The introduced Hsp60-GFP is visible as a group of GFP 
emitting at 502 nm.  The grouping of the GFP is thought to be due mostly to the 
collection of GFP into the larger chaperonin60 complex (one GFP bound to each 
of the 14 Hsp60 proteins).  As the larger chaperonin60 complexes are broken 
down the Hsp60-GFP may be grouped into vesicles and remain visible or 
dissipate below the resolution of the microscope as singular GFP signals. 
A powerful feature of the confocal approach is found in its accompanying 
software which can be used to determine colocalisation of up to four different 
fluorescent signals.  This section looks at the transfection of HeLa cells with an 
Hsp60-GFP and then investigates the colocalisation of the GFP signal with the 
signal emitted by Mitotracker.  It further looks at the possibilities of using this 
technique to detect variance between known stressors of mitochondria, where the 






4.2.1 HeLa Cell Culture 
The human epithelial cancer cell line, HeLa, was purchased from the American 
Tissue Culture Collection (ATCC number: CCL-2).  The cells were grown in 
DMEM (1x) (Gibco, Life Technologies) with additional 25 mM glucose and 1mM 
pyruvate.  The media was also supplemented with 4.5 mM NaCOH3, 2 ml 1x 
penicillin/streptomycin and 1% MEM-NEAA (100x) amino acid solution (Gibco, 
Life Technologies).  Fetal bovine serum (FBS) was added to make a 10% FBS 
DMEM media.  Cells were grown in a humidified incubator at 37
o
C, 5% CO2 
using standard incubation conditions.  Cells were passaged every 7 days by 
centrifugation (Megafuge 1.0) at approximately 400 rcf and resuspended in pre-
warmed HeLa media.      
 
4.2.2 Transfection of HeLa Cells with RG224428 
Lipofectamine 2000 reagent (Invitrogen) was purchased as a working solution of 
1 mg/ml.  Opti-MEM (Gibco, Life Technologies) is a reduced-serum media used 
during the transfection process to optimise transfection yields (as discussed in 4.1).     
HeLa cells were grown in wells on 4-well glass chamber slides (Lab-Tek) with 
initial seedings of approximately 7,800 cells per ml in pre-warmed HeLa DMEM 
media.  When the cells reached approximately 50% confluence (or approximately 
168,000 cells per ml) they were considered ready for transfection. 
The general transfection protocol was adopted from the manufacturer’s 
instructions for transfection with lipofectamine 2000.  An aliquot of 20 µl opti-
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MEM was added to tubes in row 1 and 25 µl opti-MEM was added to tubes in row 
2.  RG224428 DNA (1 µg) in endotoxin-free TE (QIAGEN) was added to each 
tube in row 1 while 1 µl Lipofectamine 2000 was added to each tube in row 2.  
The samples were incubated for 5 min at room temperature (RT).  The contents of 
the tubes in row 1 were added to the matching tubes in row 2, respectively (tube A 
from row 1 added with tube A in row 2), to make transfection media.  The newly 
mixed samples were incubated at RT for 20 min. 
HeLa growth media was removed from each well and the cells washed in 200 µl 
pre-warmed PBS pH 7.4 (37
o
C).  The cells were washed again in 200 µl pre-
warmed opti-MEM (37
o
C).  50 µl of transfection media was added drop-wise to 
each well covering the cells.  Another 150 µl pre-warmed opti-MEM (37
o
C) was 
added to each well to ensure desiccation was avoided during incubation.  The cells 
were incubated at 37
o
C for 3 h under normal incubator conditions. 
The transfection media was removed and the cells were washed in 200 µl pre-
warmed DMEM (37
o
C) where then 1 ml pre-warmed DMEM (37
o
C) was added 
and the cells incubated at 37
o
C under normal incubator conditions. 
Transfection efficiency was analysed using a Nikon Eclipse TS100 inverted 
microscope with a UV block and appropriate filters.  Imaging was performed 
using a Nikon Coolpix 4500 digital camera.  20X magnification was used to view 
transfected cell cultures.  In each frame, the number of transfected cells were 
counted and divided by the amount of total cells.  They were then multiplied by 
100 to bring it to a percentage. 
Transfected cells were characterised by a distinct green fluorescence being 
emitted under UV light excitation.  Many cells would emit this green fluorescence 
but only those that had a ‘stencilled-cell’ appearance were counted as ‘transfected’.  
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This ‘stencilled-cell’ appearance can be seen in Figure 4.8.  The reason for this 
high standard was due to the use of colocalisation in later experiments (sub-
section 4.2.5).  Hsp60-GFP would be imaged alongside fluorescently stained 
mitochondria.  By avoiding weakly fluorescent cells we could determine to best 
transfection ratios (DNA:lipofectamine etc.) to produce the most fluorescently 
‘stencilled-cells’.  A key problem with imaging live cells is that particles in the 
media can refract the light used to calculate colocalisation.  This creates enough 
background noise that it can overwhelm the detection of weakly emitting cells.  
High background noise causes researchers to increase the thresholds of 
fluorescent signal detection.  Higher thresholds of detection eliminate much of the 
information in all cells.  It can also give false-positive readings to non-transfected 
cells as they appear to have GFP signals (generated by noise).  By selecting a 
transfection method that produced very bright ‘stencilled’cells’ on top of a 
dimmer green background (made up of transfected cells that weakly emit 
fluorescence) it would benefit the more time-intensive confocal microscopy 
(colocalisation).  Equation 4.1 was used to calculate the relative transfection 
efficiency of RG224428 in HeLa cells. 
 
 
Equation 4.1 – Calculating relative transfection efficiency of RG224428 in HeLa cells 
 
4.2.3 Propidium Iodide Staining of HeLa Cells 
In order to test if the Hsp60-GFP transfection was toxic to HeLa cells propidium 
iodide was used.  Propidium iodide binds to nucleic acids and can be used to 
detect specific cell necrosis in cultures.  The peak absorption is at 535 nm and the 
% Transfection efficiency = (Hsp60-GFP cells / cells) * 100 
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peak emission is at 617 nm.  Propidium iodide was stored as a stock solution of 
1.5 mM (commonly 1 mg/ml) in sterile water.  A ‘working solution’ of 150 µM 
was made by diluting 2 µl propidium iodide in 198 µl DMEM. 
The growth media was removed from HeLa cells and the cells were washed in 
pre-warmed PBS pH 7.4 (37
o
C), before adding 200 µl of propidium iodide 
working solution.  The cells were incubated at RT for 5 min and the staining 
solution was removed and the cells were again washed in 200 µl PBS pH 7.4.  




Equation 4.2 – Calculating relative cytotoxicity of Hsp60-GFP in transfected cells 
  
4.2.4 Mitotracker RED CMX Ros Staining of HeLa Cells 
Mitotracker RED CMX Ros is a fluorescent dye that has peak absorption at 578 
nm and a peak emission at 599 nm, producing a strong red fluorescence.  The 
fluorescence of Mitotracker CMX Ros is dependent on actively respiring 
mitochondria where it then becomes oxidised and binds to the mitochondria 
(Lemasters & Ramshesh 2007; Terai & Nagano 2008).  A stock solution of 1 mM 
was made according to the manufacturer’s manual by adding 94 µl DMSO to 50 
mg Mitotracker RED CMX Ros.  A ‘working solution’ of 500 nM was made by 
diluting 10 ml stock solution in 9.99 ml to make 1 µM where upon the 1 µM 




% Cytotoxicity = (PI stained Hsp60-GFP cells / Hsp60-GFP cells) * 100 
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The growth media was removed from HeLa cells and the cells washed in pre-
warmed PBS pH 7.4 (37
o
C), before adding 200 µl of Mitotracker RED CMX Ros 
working solution.  The cells were incubated at 37
o
C for 10 min, and then the 
staining solution was removed and the cells were washed in 200 µl of PBS pH 7.4. 
The cells were viewed under a Nikon Eclipse TS100 inverted microscope with a 
UV block and appropriate filters.  Images were collected with a Nikon CoolPix 
4500 digital camera.  An Olympus FV1000 laser scanning microscope (LSCM) 
was used to collect higher resolution images using the Olympus FluroView 
software (ver1.6a). 
 
4.2.5 Stressing Transfected HeLa Cells 
After transfection had been performed on the cells (4.2.2) a number of treatments 
were employed to stress the cells in order to investigate the movement of the 
Hsp60-GFP out of mitochondria.  Treatments of 100 mM glucose and 25 µM 
sodium azide were chosen to stress the cells as they have been known to induce 
increased Hsp60 expression (personal communication, Hall).  The control group 
was grown in normal HeLa DMEM media (4.2.1).  The ‘100 mM glucose group’ 
was grown in HeLa DMEM media laced with added glucose.  The concentration 
of glucose was brought to 100 mM by adding 0.135 g of glucose with HeLa 
DMEM media to make 10 ml.  The ‘25 µM sodium azide’ treatment was made 
using sodium azide and HeLa DMEM media. Sodium azide (0.065 g) was diluted 
with HeLa DMEM media until it was at a concentration of 25 µM sodium azide in 
10 ml HeLa DMEM media (detailed in 2.1).  The transfected cells were grown in 
2 ml of each treatment and incubated at 37
o
C with 5% CO2 under normal 
incubator conditions.  When confocal imaging was performed the flourodish 
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being analysed was kept in an incubator built around the confocal microscope at 
37
o






HeLa cells were grown successfully in HeLa DMEM media as shown by Figure 
4.1.  At four days the growth begins to curve off and plateau.  This corresponds 
with the cells reaching confluence in the flask.  Each week the cells were passaged 
and a new flask seeded with approximately 80,000 cells. 
 
Figure 4.1 – Growth chart for HeLa cell culture over 8 days.  Error bars showing S.E.M. 
 
The picture in Figure 4.2 shows a standard image of HeLa cells while the pictures 
in Figure 4.3 show the effect of transfection with RG224428.  In this visual 
comparison the bright green in Figure 4.3b represents HeLa cells synthesising the 
GFP bound Hsp60 protein from RG224428.  The GFP is fluorescing light at 








Figure 4.3 – HeLa cells transfected with RG224428 24 h after transfection.  a) A frame 
of transfected HeLa cells under normal light.  b) The same frame of transfected 
fluorescent HeLa cells under a UV light with a 550 nm filter.  Both photos performed 
using 20X magnification on inverted wide field microscope.  Transfected cells were 
characterised by a bright green ‘stencilled-cell’ appearance (4.2.2). 
 
The transfection times were analysed to obtain data on transfection efficiency.  
The threshold of inclusion was relatively high for transfected cells (as detailed in 
4.2.2).  By varying the time that the HeLa cells spent in the transfection media we 
were able to detect a steady decrease in the rate of transfection.  A time of 3 hours 




slight decline to 1.67 ± 0.21%.  The longest time of 5 hours saw a reduction in 
transfection efficiency by nearly half at 1.13 ± 0.08% (Figure 4.4).  Upon further 
inspection student’s t-tests revealed that there was no statistical significance 
between the three times.  This occurred despite the S.E.M. showing substantial 
differences in boundaries between ‘3 hours’ time and the other two time varients.  
The difference between the ‘4 hours’ and ‘5 hours’ times did approach 
significance (p < 0.05) but still showed insignificant differences with the 3 hour 
time.  According to our data, a transfection time of 3 hours is possibly the best as 
it uses the least amount of time and it achieves a transfection efficiency just as 
substantial as longer times.   
The ratio of DNA and lipofectamine 2000 in the transfection media was 
investigated to assess what ratio could produce the best transfection efficiency.  
As lipofectamine 2000 is expensive the ratios were kept within feasible 
boundaries.  Ratios are designated as DNA:lipofectamine 2000 in μl sized aliquots.  
The ratio of 1:0.5 had a transfection efficiency of 1.64 ± 0.24% while 1:1 had the 
highest success with a ratio of 4.02 ± 1.41%.  There was a substantial drop in the 
mean transfection efficiency when moving up to higher lipofectamine 2000 ratios.  
The 1:2 ratio samples had a mean of 1.50 ± 1.16% while the ratio for 1:3 had a 
mean of 21.3 ± 1.03% (Figure 4.5).  Despite the observable difference in mean 
transfection efficiency there were no statistically significant differences between 
any DNA to lipofectamine 2000 ratios.  The 1:1 ratio showed near significant 
differences between 1:1 against both 1:0.05 and 1:2 but failed to gain significance.  
Due to the relatively high mean the 1:1 ratio was used in future transfections.  
Even though using 0.05 μl and 2μl of lipofectamine proved a similar efficiency, it 
was decided that the irregularly high transfection efficiencies (1:1 as high as 
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7.56%; the highest 1:0.05 was 2.31%) that contributed to the insignificantly high 
mean were worth our attention.  
 
 
Figure 4.4 – Transfection efficiency of HeLa cells left in RG224428 transfection solution 
over different times.  Bar graph showing the mean ± S.E.M. 
 
 
Figure 4.5 – Transfection efficiency of HeLa cells with differing RG224428 transfection 
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To assess whether the transfected cells were causing unwanted necrotic damage, 
propidium iodide (PI) was used to stain exposed nucleic material (Figure 4.6b).  
Assessing the control group showed the average amount of transfected cells that 
had PI staining within their vicinity was 3.76 ± 0.53%.  There was no significant 
change in PI staining over the three days.  The glucose treatment showed a similar 
trend with an average of 2.13 ± 1.93% and no significant changes over the three 
days.  The sodium azide group had a significantly higher mean at 11.3 ± 4.3% 
which was due to a spike at 48 h (p < 0.05). 
In order to detect successful colocalisation between the Hsp60-GFP and the HeLa 
cell mitochondria, Mitotracker RED CMX Ros (commonly referred to as 
mitotracker or CMX Ros) was used to stain the mitochondria cell culture.  Figure 
4.7a shows HeLa cells stained with mitotracker while Figure 4.7b shows the 
Hsp60-GFP simultaneously stained with mitotracker.  Mixing of the two 
fluorescent signals can be seen clearly on the left of Figure 4.7b.   
 
 
Figure 4.6 – HeLa cells transfected with RG224428 and stained with propidium iodide.  
a) A frame of transfected HeLa cells under normal light.  b) The same frame of 
transfected fluorescent HeLa cells under a UV light with a 550 nm filter.  Both photos 






Figure 4.7 – HeLa cells transfected with RG224428 and stained with Mitotracker CMX 
Ros.  a) A frame of transfected HeLa cells under a UV light with a 700 nm filter.  b) The 
same frame of transfected fluorescent HeLa cells under a UV light with a 550 nm filter.  
Both photos performed using 20X magnification on inverted wide field microscope. 
 
The colocalisation between the GFP signal emitted from the Hsp60-GFP (green; 
transcribed from RG224428) and Mitotracker CMX Ros (red; used to label host 
mitochondria) was analysed using an Olympus FV1000 inverted laser scanning 
confocal microscope.  The degree of colocalisation was calculated using Olympus 
FluroView software (ver1.6a).  The statistic of interest used to determine 
colocalisation was the overlap coefficient (r), derived from Pearson’s coefficient 
(used to detect overlapping signal intensities per pixel).  Due to variance in the 
signal intensities in our work, r is used as it ignores signal intensity.  The r statistic 
calculates the degree of overlap from 0 to 1, 1 being a perfect 1:1-overlap between 
signals (0 being no overlap).  Three different treatments (explained by their names) 
were used to detect differences in Hsp60-GFP-mitochondria colocalisation, 
‘control’, ‘100mM glucose’ and ‘25μM sodium azide’ (hereafter referred to as 
control, glucose and sodium azide, respectively). 
Figure 4.8-4.9 show images captured by us on a laser scanning confocal 
microscope (60X magnification).  The imaged cells are HeLa cells transfected 
with RG224428.  Figure 4.8 has an r value of 0.78 indicating a high degree of 




over each other.  False colours have been used to highlight the different channels 
(the confocal detect signals as different shades of grey).  a) shows the fluorescent 
GFP signal. b) shows the mitotracker signal and c) shows the two signals 
superimposed.  The yellow pixels indicate sites of colocalisation.  Figure 4.8d 
shows the cell being imaged under normal light.  e) shows the GFP signal 
superimposed over the normal light image.  f)  shows the two fluorescent signals 
superimposed over the cell.  Figure 4.9a-f show the same properties as mentioned 
for Figure 4.8a-f but the cell has much less colocalisation as calculated by the r 




Figure 4.8 – Confocal laser scanned image of a transfected HeLa cell in false colour 
(green represents the Hsp60-GFP signal; red represents Mitotracker RED CMX Ros).  










Figure 4.9 – Confocal laser scanned image of a transfected HeLa cell in false colour 
(green represents the Hsp60-GFP signal; red represents MitotrackerREDCMX Ros).  Cell 










The following figures (Figure 4.10; Figure 4.11; Figure 4.12) show images of 
transfected cells in the control, glucose and sodium azide groups, respectively.  
Each figure shows images of cells within each group taken at the time points 24, 
48 and 72 h (a), b) and c), respectively).  In each series of pictures the signal for 
mitotracker (left) is shown followed by the Hsp60-GFP signal (middle).  The 
images are then overlaid, 1:1, to reveal points of colocalisation in yellow (right).  
An increase in colocalisation is shown in Figure 4.10 between a) and c) as 
evidenced by the r values 0.70 and 0.75, respectively.  The images in b) appear to 
capture 3 different cells expressing Hsp60-GFP.  Figure 4.11 shows the decrease 
in colocalisation over time in glucose group cells (0.76, 0.67 and 0.58 for a), b) 
and c), respectively.  The image in c) appears indicative of a cell under stress.  
Large vesicles of mitochondria (red) and Hsp60-GFP (green) can be seen around 
the nuclei.  Figure 4.12 shows the state of colocalisation for the sodium azide 
group at 24, 48 and 72 h (a), b) and c), respectively).  The r values for a), b) and c) 




   
   
   
Figure 4.10 – Colocalisation of Hsp60-GFP with mitotracker in control group using false 
colour (red = mitotracker; green = Hsp60-GFP; yellow = colocalisation between the two 







   
   
   
Figure 4.11 – Colocalisation of Hsp60-GFP with mitotracker in glucose group using 
false colour (red = mitotracker; green = Hsp60-GFP; yellow = colocalisation between the 







   
   
   
Figure 4.12 – Colocalisation of Hsp60-GFP with mitotracker in sodium azide group 
using false colour (red = mitotracker; green = Hsp60-GFP; yellow = colocalisation 







Figure 4.13 shows the changes in the mean overlapping values for the control 
group.  At 24, 48 and 72 h the varied means are 0.65 ± 0.02, 0.69 ± 0.02 to 0.72 ± 
0.01 respectively.  The increased overlap between 24 h and 72 h was significant (p 
< 0.05).  It shows an increase in colocalisation by approximately 7% from 24 h to 
72 h.  Figure 4.14 shows the changes in the mean overlapping values for the  
glucose group.  A different pattern could be seen immediately when compared to 
the control group.  There appeared to be a decline in the colocalisation of Hsp60-
GFP and Mitotracker CMX Ros signals.  At 24, 48 and 72 h the varied means are 
0.69 ± 0.03, 0.66 ± 0.03, 0.60 ± 0.04 respectively.  Using a two-tailed student’s t-
test revealed no significance differences between the means of 24, 48 and 72 h (p > 
0.05).   However, a single tailed test showed that there was a significant decrease 
from 24 to 72 h (p < 0.05), the significance being between 24 and 72 h 
specifically (by approximately 9%).  The graph in Figure 4.15 shows the mean 
overlap coefficient for the sodium azide treatment.  Using the overlap coefficient 
revealed no significant differences between the means of 24, 48 and 72 h (p > 
0.05).  Scaling down to a single tailed student’s t-test showed change to 
significance.  The differences between the means however still showed varied 
colocalisation.  Data from 24 h had a mean of 0.69 ± 0.02 with a 48 h mean of 
0.66 ± 0.02 while 72 h had a mean of 0.73 ± 0.03  There appeared to be a sudden 
(but insignificant) spike in colocalisation at 72 h.   
 
   




Figure 4.13 – The overlap coefficient (r) means for the control group at 24, 48 and 72 
hours.  Bar graph showing the mean ± S.E.M.  
 
 
Figure 4.14 – The overlap coefficient (r) means for the 100mM glucose group at 24, 48 









Figure 4.15 – The overlap coefficient (r) means for the 25μM sodium azide group at 24, 
48 and 72 hours.  Bar graph showing the mean ± S.E.M.  
 
 
Figure 4.16 – The overlap coefficient (r) means for the all three treatments at 24, 48 and 
72 hours.  The blue, red and green bars show means for control, 100 mM glucose and 25 
μM sodium azide, respectively.  Bar graph showing the mean ± S.E.M. 
 
The data seen in Figure 4.16 shows all three treatments assessed side-by-side.  At 
24 h were no significant differences between the degrees of colocalisation 
between Hsp60-GFP and mitotracker for all treatments.  The same was found for 





























































a significant, and relatively substantial, difference was observed between the 
control and the glucose treatments.  This same significance was observed between 
the sodium azide and glucose treatments.  The 72 h figures for the control and 
glucose treatments were 0.72 ± 0.01 and 0.60 ± 0.04.  This indicates a difference 
in colocalisation of approximately 12%.  The 72 h figure for sodium azide was 










The human Hsp60 is an important protein that resides in the mitochondria of 
human cells.  It has roles in protein folding, chaperoning denatured proteins and in 
the intracellular stress response (Gupta & Knowlton 2005; Quintana & Cohen 
2011).  Hsp60 has been more recently implicated in intercellular signalling and 
that it shares receptors with cell stressors such as LPS (Cohne-Sfady et al. 2005).  
It was also found that diabetic patients had elevated levels of Hsp60 in saliva and 
serum samples (Yuan et al. 2011).  In this chapter HeLa cells were transfected 
with RG224428, a plasmid encoding a human Hsp60 with a GFP protein attached 
to the C-terminus.  Transfected cells were treated with high glucose (to simulate 
hyperglycaemia) and sodium azide (a mitochondrial stressor).  The Hsp60-GFP 
was then analysed on a confocal microscope and its colocalisation with 
Mitotracker CMX Ros (used to stain actively respiring mitochondria) was 
calculated.  
Modern day HeLa cells are derived from a human cervical cancer cell line 
originating from 1951 (Ursano 2012).  As such, they are mammalian and possess 
a phenotype similar to normal human cells (though immortalised).  They can be 
grown in media designed to emulate a human biological system and due to their 
robust nature they are useful for scientific studies.  Some researchers have used 
HeLa cells to study mitochondrial diseases such as mitochondrial 
encephalomyopathy (Isobe et al. 1997).  HeLa cell nuclei were replaced with 
nuclei from patients suffering mitochondrial diseases in order to establish if the 
complications were caused by mutations in mitochondria (or chromosomal DNA).  
Bouvard et al. (2002) transfected HeLa cells with the tat gene from human 
immunodeficiency virus 1 (HIV1).  This caused a reduction in the cells’ ability to 
cope with glucose.  Their work showed that Mn-dependant superoxide dismutase 
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(Mn-SOD; reduces superoxide to O2 and H2O2) was impaired with a 50% 
reduction in activity causing glucose cytotoxicity.  Recently HeLa cells were 
transfected to produce a pH sensitive protein which fluoresces in acidic conditions.  
This was used to understand the acidic properties of intracellular organelles.  
Diseases such as cancer and Alzheimer’s disease have been linked to abnormal 
cellular pH conditions (Lv et al. 2013). 
In our research HeLa cells were transfected with the plasmid RG224428 (Figure 
3.1) which encodes a human Hsp60-GFP.  A lipid based transfection agent, 
Lipofectamine 2000 (Invitrogen), was used to deliver the plasmid into the cytosol 
of the HeLa cells (detailed in 4.2.2).  The highest average transfection efficiency 
we could achieve with our methods was ~4%.  This result is considerably very 
low to what has been reported in the literature.  Susa et al. (2008) reported 
transfection efficiencies in fluorescence emitting cells as high as 20% using 
Lipofectamine 2000.  This represents a 5-fold increase over our results.  Some key 
differences were they used the gonadotrope cell line LβT2 and they achieved this 
efficiency using much less DNA (10 ng).  β-galactosidase transfection assays have 
been used to detect transfection efficiencies.  These assays require that the gene 
for β-galactose be translated by cells in order to digest galactose products usually 
linked with a marker that changes colour upon digestion (Li et al. 2012).  Using β-
galactosidase assays, Yomano et al. (2010) tested the transfection efficiencies of 
various cell types with various different transfection reagents.  HeLa cells 
transfected using lipofectamine 2000 were among their tests.  Out of six different 
transfection reagents (Arrest-In (Thermo Scientific); ExpressFect (Denville 
Scientific); FuGENE HD(Roche); jetPEI(Polyplus-Transfection); Lipofectamine 
2000 (Invitrogen); Superfect (Qaigen)) Lipofectamine 2000 showed the lowest 
efficiency for β-galactosidase methods excluding serum.  It was the second lowest 
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when 10% serum was used. Their data also show that efficiency changes between 
cell lines.  In C2C12 mouse myoblasts Lipofectamine 2000 had a ~4-fold lower 
efficiency than jetPEI (Yomano et al. 2010).  Variables such as cell type and 
transfection reagent may need to be reconsidered in future tests using our methods.  
There may be other cells that can incorporate the Hsp60-GFP more readily.  
Despite low transfection efficiency HeLa cells were successfully transfected and 
proved useful for our study.   
Propidium iodide (PI) is a fluorescent probe used to detect cellular damage by 
binding to exposed DNA (Lin et al. 2007; Knowlton & Uma 2008).  We stained 
transfected HeLa cells with PI and found that an average of ~4% of transfected 
cells were colocalising with PI (on a wide-field microscope; 20X magnification).  
This suggested that the Hsp60-GFP posed very low-to-no toxicity to the cells. 
Hsp60 expression is upregulated with many types of cellular stress.  Upregulation 
can be as high as 10% in stress induced cells.  The increased Hsp60 is thought to 





C have seen 30-40% increases in polypeptide binding with 
Hsp60 (Martin et al. 1992).  Sarri et al. (2009) found that Hsp60 expression is 
significantly increased after cardiac allograft rejection events in heart transplant 
patients.  Data collected from biopsies showed Hsp60 levels of 8.94 pg/ml and 
14.92 pg/ml for samples taken during rejection and recovery, respectively.  Hsp60 
in blood serum samples from type 2 diabetic patients showed dramatic increases.  
Non-diabetics had levels as high as 7 ng/ml while diabetics had levels as high as 
75 ng/ml (Yuan et al. 2011).  Hsp60 has been found expressed on the surface of 
various cell types.  Hsp60 expressed on the surface of pancreatic β-cells has been 
linked with T-cell mediated insulitis (Birk et al. 1996).  Since Hsp60 
predominantly resides in mitochondria and is released in times of stress, we 
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wanted to investigate the changes in colocalisation between Hsp60 and 
mitochondria.  In our study we used HeLa cells transfected with an Hsp60-GFP. 
Mitochondria were stained with Mitotracker CMX Ros.  Where many have used 
fixed-cell preparations we employed three conditions on live cells growing in 
media.  The colocalisation analyses were performed using and Olympus FV1000 
laser scanning microscope.  The overlap coefficient (‘r value’; derived from 
Pearson’s correlation) was used to calculate the degree of colocalisation.  The 
overlap coefficient was used instead of Pearson’s correlation because the Pearson 
correlation requires the fluorescent signals to be of equal intensity.  We found that 
the intensity of the chemically based mitotracker was consistent between cells but 
the biologically derived Hsp60-GFP was not.  When colocalising the two signals 
it was clear that the intensities were very different. 
We found that the control group had a significant ~7% increase (p < 0.05), from 
24 h to 72 h in the colocalisation between the mitotracker and Hsp60-GFP signals.  
This change over time may be due to our induced Hsp60-GFP competing for 
mitochondrial uptake with the endogenous Hsp60.  At 24 h there may be GFPs 
attached to the pre-peptide Hsp60s that emit fluorescence in the cytosol while the 
Hsp60 is still in a peptide form awaiting uptake into mitochondria.  This increase 
overtime has been observed in other studies.  Jayakumar et al. (2001) waited 4 
days to allow for transfected cells to produce optimal levels of Hsp70 before 
testing isheamia and reperfusion stress in rat hearts. 
An important aspect of our methods to consider is that inducing overexpression of 
Hsp60 may alter the cells ability to cope with stress.  A study using a viral vector 
containing Hsp72 to transfect porcine renal tubular epithelial cells (LLC-PK1 
cells) showed that the introduced vector caused overexpression of Hsp72.  The 3-
fold increase in Hsp72 expression was correlated with a significant increase in 
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resistance to H2O2 and cisplatin (a pro-apoptotic drug) stress (Komatsuda et 
al.1999).  This type of response would be difficult to avoid in our methods but 
insuring the controls are well represented alongside the treatments would provide 
the necessary clarity.  
The glucose (100 mM) treatment showed a decline in colocalisation by ~9% (p < 
0.05) after 72 hours.  Relative to the control group the glucose group had a total 
decline of ~12% (p < 0.05) in colocalisation between the Hsp60-GFP and 
mitotracker signals.  In normal healthy cells 80 – 85% of Hsp60 is found within 
mitochondria leaving 15 – 20% in the cytosol (Knowlton & Srivatsa 2008).  
Hsp60 has been found to be upregulated by up to 10% during stress (Pockley 
2002).  More research would be required to investigate a connection between the 
~12% change we observed in Hsp60 expression with the similar levels of 
upregulation in other studies (Pockley 2002).  Another factor to consider is that 
Hsp60 has been found to accumulate in the cytosol without disrupting 
mitochondrial Hsp60 levels (Chandra et al. 2007). 
Sodium azide is a highly toxic substance that has been used to stress mitochondria 
in earlier research (Leary et al. 2002; Ishikawa et al. 2006).  The toxic properties 
of sodium azide arise from its interaction with complex IV of the electron 
transport chain in mitochondria.  It binds to the Fe
3+
 in cytochrome c oxidase 
(complex IV) which in turn cancels the oxidative phosphorylation vital to 
sufficient ATP production (Ishikawa et al. 2006).  Concentrations as low as 10 
µM have been found to adversely affect mammalian cells by reducing complex IV 
activity (Leary et al. 2002).  Ishikawa et al. (2006) found that different tissues can 
have differing levels of tolerance to sodium azide.  They found myocardial and 
nerve cells to be more sensitive than fibroblast, liver and kidney epithelial tissue.  
They also noted that mitochondria stressed with sodium azide had atrophied.  We 
 104 
 
initially expected to see a reduction in mitotracker uptake in cells stressed with 
sodium azide as well as a disruption in mitochondrially-bound Hsp60-GFP.  As 
these conditions were not apparent future sodium azide treatments will need to be 
tested using MTT assays to ensure mitochondrial activity is being inhibited. 
Further testing will be required to establish by what means the colocalisation 
declines in high glucose concentrations.  Fluorescent probes for lipid rafts may 
prove useful in detecting the movement of Hsp60 out of mitochondria.  Lipid rafts 
can translocate around the cytosol and bind with membranes.  The inhibition of 
lipid raft creation has reduced Hsp60 translocation in studies before (Merendino et 
al. 2010).  It may be found that a decrease in Hsp60-GFP and mitotracker 
colocalisation my lead to an increase in Hsp60-GFP colocalisation with probes 
bound to lipid rafts.  Assays calculating mitochondrial Hsp60 and cytosolic Hsp60 
may provide the information needed to establish whether the observed decrease in 
colocalisation is by Hsp60-GFPs translocation out of mitochondria or the 




5 Final Summary and Future Directions 
In this study, live HeLa cells were transfected with an Hsp60-GFP to determine if 
they could be used to study the colocalisation between the Hsp60 protein and 
mitochondria.  The plasmid RG224428 containing the Hsp60-GFP was 
successfully cloned and purified, in and from DH5α E. coli. 
Using Lipofectamine 2000 HeLa cells were transfected with a transfection 
efficiency of ~4%.  In order to improve the transfection efficiency a control 
plasmid (GFP only) may need to be employed to test the interaction between the 
Hsp60-GFP and the HeLa cells.  By varying the conditions HeLa is grown in we 
may find that an additional Hsp60 gene source may be treated differently to the 
chromosomal gene.  Diabetic hyperglycaemia has been linked to an increase in 
Hsp60 expression in the circulation (Jax 2010; Yuan et al. 2011) and other studies 
have found that Hsp60 can be upregulated during stress (Shafler et al. 2002; 
Gupta & Knowlton 2005).  The growth media we used to grow HeLa cells had a 
glucose concentration of 25 mM.  This higher glucose concentration was several 
times higher than the >11.1 mM concentration that describes diabetes (World 
Health Organisation 2006).  The high glucose environment in the growth media 
that preceded the transfection media may have altered or upregulated the 
chromosomal Hsp60.  This may have had a negative effect on the expression of 
the introduced Hsp60-GFP.  Future studies may need to test transfection 
efficiencies in cells grown in media with lower glucose concentrations.  Different 
transection reagents may also provide greater efficiencies.  Tests have shown that 
transfection reagents can achieve different transfection yields.  Other cell types 
may also provide more efficient platforms to transfect with an Hsp60-GFP 
(Yomano et al. 2010). 
 106 
 
Despite the low transfection efficiency staining with propidium iodide determined 
that the transfection imposed very low-to-no toxicity in the HeLa cells.  Staining 
cells with Mitotracker CMX Ros revealed the successful uptake of Hsp60-GFP to 
mitochondria.  Using laser scanning confocal microscopy it was shown that 
growth media adjusted to hyperglycaemic conditions (100 mM glucose) caused 
~12%  of the Hsp60-GFP signal to translocate out of the mitochondria and into 
the cytosol after 72 hours.  Our research suggests that hyperglycaemic stress my 
cause a disruption in normal mitochondrial Hsp60 expression.  It also suggests 
that the balance between mitochondrial and cytosolic Hsp60 may be altered by the 
translocation of more Hsp60 into the cytosol.   
Other researchers have found that stress can disrupt the expression of Hsp60.  A 
study of Hsp60 cell surface expression was performed on human umbilical vein 
endothelial cells (HUVECs).  When cells were heat-shocked (42
o
C) they showed 
increased surface expression of Hsp60.  The heat-shocked cells showed a 10% 
increase in surface expression when compared to non-heat-shocked controls 
(Pfister et al. 2005).  Tsuei & Martinus (2012) found that metformin, an anti-
hyperglycaemic agent used for diabetic therapy, could increase levels of Hsp60 
mRNA in human acute monocytic leukaemia (THP-1) cells.  At higher levels (500 
µM) it could induce an upregulation of the Hsp60 protein within the cells by 26-
fold.  Not all cells have been found to upregulate Hsp60 during stress.  In a study 
by Barutta et al. (2008) it was found that human podocytes (involved in kidney 
filtration) and mesangial cells (support capillaries in the kidney) exposed to high-
glucose (25mM; 4-fold lower than our treatment) and mechanical stress did not 
increase Hsp60 expression.  (Shan et al. 2010) found that hyperglycaemia can 
inhibit the synthesis of Hsp60 in murine cardiomyocytes by upregulating the 
microRNAs miR-1 and miR-206.  The researchers found that hyperglycaemia was 
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responsible for increasing the expression of miR-1 and miR-206 which 
downregulated Hsp60 allowing apoptosis to take place.  Hyperglycaemic stress 
has been linked to the modification of cytosolic Hsp60.  Kim et al. (2006) found 
that O-N-acetylglucosamine (O-GlcNAc), a glucose-derived product formed by 
the hexosamine pathway, bound to cytosolic Hsp60 in rat β-cells during 
hyperglycaemia.  They also found a two-fold increase in Bax expression in 
mitochondria.  As cytosolic Hsp60 is normally bound to the pro-apoptotic protein 
Bax, hyperglycaemia was found to disrupt this binding. 
Hsp60 has been described as a potential biomarker for stress (Quintana & Cohen 
2011).  It has been found expressed in exosomes (nm-sized vesicles) secreted by 
human cancer cells (Meredino et al. 2010).  These exosomes are considered to be 
an important path used to translocate Hsp60 to nearby cells and into the 
circulation (Campanella et al. 2012).  Type 1 diabetic patients (prone to 
hyperglycaemia) have shown increased levels of Hsp60 in the circulation 
accompanied by its increased liganding with TLR4 receptors (Devaraj et al. 2009).  
It was also found that type 2 diabetic patients had elevated levels of Hsp60 in 
saliva and serum samples (Yuan et al. 2011).  Studies outside of diabetes and 
metabolic stress have also shown elevated Hsp60 in blood samples.  Wheeler et al. 
(2007) found that levels of Hsp60 in the blood-serum samples of children 
suffering septic shock were significantly higher. 
Our approach to better understand the relationship between Hsp60 and 
mitochondria during stress employed fluorescent-confocal microscopy.  We found 
this method very effective in determining colocalisation in living cells.  As Hsp60 
can be used as a biomarker for many different stress conditions, we suggest future 
studies use our methods to investigate other cellular stressors and their relative 
therapies.  An advantage in these methods is that specific living cells can be 
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accurately monitored over short periods of time while stressors and therapeutic 
agents are administered.  This may help calculate the rates at which stressors and 
therapies act within cells. 
By adding fluorescent tags to cytosolic transportation vesicles these methods may 
be used to further determine the pathways used to translocate other Hsps.  Chen et 
al. (2005) used western blotting to quantify the amounts of different heat shock 
proteins (Hsps 90, 70, 60 and 40) found in lipid rafts extracted from rat brain.  
They found that the Hsps were expressed in the lipid rafts of non-stressed neurons 
and upon hyperthermic treatment Hsp70 was increased.  Use of an Hsp70-GFP 
with our methods could help quantify the degree of colocalisation between Hsp70 
and fluorescently-labelled lipid rafts before and after hyperthermic treatment in 
live neurons.  Hsp60 has been found in the lipid rafts of cancer cell lines 
(Merendino et al. 2010) and the lipid rafts and exosomes secreted by cardiac 
myocytes (Gupta & Knowlton 2006).  Gupta & Knowlton (2006) performed 
hypoxia on cardiac myocytes and found evidence suggesting the Hsp60 expressed 
in secreted exosomes originated from lipid rafts within the stressed cells.  The use 
of Brefeldin A (inhibits transport of proteins from the endoplasmic reticulum to 
the Golgi apparatus) showed that Hsp60 was translocated to exosomes by a 
pathway other than the common protein secretion pathway (using the Golgi 
apparatus).  Hsps using lipid raft based secretion have been found in other cell 
types.  Heat shocked peripheral blood mononuclear cells have shown that Hsp70 
can be secreted in the presence of Brefeldin A (Lancaster & Febbraio 2005).  Our 
methods may help to determine the path cells use to secrete heat shock proteins by 
using colocalisation techniques.  This may be a novel way to test therapies 
designed to reduce the Hsp60 secretion observed in diabetic patients, potentially 
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